David Mulligan

• Bishwajit Bhattacharya
• Dhanpat Jain
• Guadalupe Garcia-Tsao
• James Duncan
• Jordan Pober
• Kimberly Davis
• Louise-Marie Dembry
• Maricar Malinis
• Michael Schilsky
• Pramod Mistry
• Ramesh Batra
• Robert Elder
• Sanjay Kulkarni
• Tamar Taddei
• Xuchen Zhang

Hepatitis; e-Health

• Living donor liver transplant candidate and donor selection and engagement: Meeting report from the living donor liver transplant consensus conferenceJesse M, Jackson W, Liapakis A, Ganesh S, Humar A, Goldaracena N, Levitsky J, Mulligan D, Pomfret E, Ladner D, Roberts J, Mavis A, Thiessen C, Trotter J, Winder G, Griesemer A, Pillai A, Kumar V, Verna E, Rudow D, Han H, Group T. Living donor liver transplant candidate and donor selection and engagement: Meeting report from the living donor liver transplant consensus conference. Clinical Transplantation 2023, 37: e14954. PMID: 36892182, DOI: 10.1111/ctr.14954.
• CRITICALITIES AND USEFULNESS OF EX-VIVO SMALL INTESTINE PERFUSION: TRANSPLANT AND BEYONDMuñoz-Abraham A, Martinez A, Aviles-Ovalle B, Patron-Lozano R, D’Amico F, Geibel J, Mulligan D, Martins P, Rodriguez-Davalos M. CRITICALITIES AND USEFULNESS OF EX-VIVO SMALL INTESTINE PERFUSION: TRANSPLANT AND BEYOND. European Journal Of Transplantation 2023, 1: 126-135. DOI: 10.57603/ejt-015.
• A review of the current and future role of robotic surgery in liver surgery and transplantationFinotti M, D’Amico F, Mulligan D, Testa G. A review of the current and future role of robotic surgery in liver surgery and transplantation. HepatoBiliary Surgery And Nutrition 2023, 0: 0-0. PMID: 36860258, PMCID: PMC9944521, DOI: 10.21037/hbsn-21-115.
• Honoring the gift: The transformative potential of transplant-declined human organsAlbert C, Harris M, DiRito J, Shi A, Edwards C, Harkins L, Lysyy T, Kulkarni S, Mulligan D, Hosgood S, Watson C, Friend P, Nicholson M, Haakinson D, Saeb-Parsy K, Tietjen G. Honoring the gift: The transformative potential of transplant-declined human organs. American Journal Of Transplantation 2023, 23: 165-170. PMID: 36695696, DOI: 10.1016/j.ajt.2022.11.015.
• Epidemiology and outcomes of surgical site infections among pediatric liver transplant recipientsBanach DB, Lopez‐Verdugo F, Sanchez‐Garcia J, Tran A, Gomez‐Llerena A, Munoz‐Abraham A, Bertacco A, Valentino PL, Yoo P, Dembry L, Mulligan DC, Ekong UD, Emre SH, Rodriguez‐Davalos M. Epidemiology and outcomes of surgical site infections among pediatric liver transplant recipients. Transplant Infectious Disease 2022, 24: e13941. PMID: 35989545, DOI: 10.1111/tid.13941.
• L-ARGININE PREVENTS ISCHEMIC INJURY IN EXPLANTED RAT INTESTINAL REGIONS IN AN EX VIVO PERFUSION MODELFinotti M, Barahona M, Maina R, Lysyy T, Agarwal R, Schmitt P, Caturegli G, Di Renzo C, Anselmo A, Mulligan D, Geibel J, D'Amico F. L-ARGININE PREVENTS ISCHEMIC INJURY IN EXPLANTED RAT INTESTINAL REGIONS IN AN EX VIVO PERFUSION MODEL. Transplantation Reports 2022, 7: 100096. DOI: 10.1016/j.tpr.2022.100096.
• Clinical and Ethical Framework for Liver Retransplantation Using Living Donor Grafts: A Western PerspectiveBatra RK, Mulligan DC. Clinical and Ethical Framework for Liver Retransplantation Using Living Donor Grafts: A Western Perspective. Liver Transplantation 2022, 28: 760-762. PMID: 34931433, DOI: 10.1002/lt.26395.
• Sustained Improvement in Patient Experience by Optimizing Patient Flow in Ambulatory SettingsPashankar DS, Brown T, Votto P, Follo M, Formica RN, Schilsky ML, Mulligan DC, Khokhar B. Sustained Improvement in Patient Experience by Optimizing Patient Flow in Ambulatory Settings. Journal Of Patient Experience 2022, 9: 23743735221092610. PMID: 35402702, PMCID: PMC8990690, DOI: 10.1177/23743735221092610.
• Inactive status is an independent predictor of liver transplant waitlist mortality and is associated with a transplant centers median meld at transplantMerola J, Gan G, Stewart D, Noreen S, Mulligan D, Batra R, Haakinson D, Deng Y, Kulkarni S. Inactive status is an independent predictor of liver transplant waitlist mortality and is associated with a transplant centers median meld at transplant. PLOS ONE 2021, 16: e0260000. PMID: 34793524, PMCID: PMC8601542, DOI: 10.1371/journal.pone.0260000.
• Developing simultaneous liver‐kidney transplant medical eligibility criteria while providing a safety net: A 2‐year review of the OPTN's allocation policyWilk AR, Booker SE, Stewart DE, Wiseman A, Gauntt K, Mulligan D, Formica RN. Developing simultaneous liver‐kidney transplant medical eligibility criteria while providing a safety net: A 2‐year review of the OPTN's allocation policy. American Journal Of Transplantation 2021, 21: 3593-3607. PMID: 34254434, DOI: 10.1111/ajt.16761.
• American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver DiseaseFix OK, Blumberg EA, Chang K, Chu J, Chung RT, Goacher EK, Hameed B, Kaul DR, Kulik LM, Kwok RM, McGuire BM, Mulligan DC, Price JC, Reau NS, Reddy KR, Reynolds A, Rosen HR, Russo MW, Schilsky ML, Verna EC, Ward JW, Fontana RJ, Group F. American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease. Hepatology 2021, 74: 1049-1064. PMID: 33577086, PMCID: PMC8014184, DOI: 10.1002/hep.31751.
• North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal HypertensionBoike JR, Thornburg BG, Asrani SK, Fallon MB, Fortune BE, Izzy MJ, Verna EC, Abraldes JG, Allegretti AS, Bajaj JS, Biggins SW, Darcy MD, Farr MA, Farsad K, Garcia-Tsao G, Hall SA, Jadlowiec CC, Krowka MJ, Laberge J, Lee EW, Mulligan DC, Nadim MK, Northup PG, Salem R, Shatzel JJ, Shaw CJ, Simonetto DA, Susman J, Kolli KP, VanWagner LB, Consortium A. North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension. Clinical Gastroenterology And Hepatology 2021, 20: 1636-1662.e36. PMID: 34274511, PMCID: PMC8760361, DOI: 10.1016/j.cgh.2021.07.018.
• The demise of islet allotransplantation in the United States: A call for an urgent regulatory update.Witkowski P, Philipson L, Kaufman DB, Ratner L, Abouljoud MS, Bellin M, Buse J, Kandeel F, Stock P, Mulligan D, Markmann JF, Kozlowski T, Andreoni K, Alejandro R, Baidal D, Hardy MA, Wickrema A, Mirmira RG, Fung J, Becker Y, Josephson MA, Bachul PJ, Pyda JS, Charlton M, Millis JM, Gaglia J, Stratta RJ, Fridell JA, Niederhaus S, Forbes RC, Jayant K, Robertson RP, Odorico J, Levy M, Harland R, Abrams PL, Olaitan OK, Kandaswamy R, Wellen J, Japour AJ, Desai CS, Naziruddin B, Balamurugan AN, Barth RN, Ricordi C. The demise of islet allotransplantation in the United States: A call for an urgent regulatory update. American Journal Of Transplantation : Official Journal Of The American Society Of Transplantation And The American Society Of Transplant Surgeons 2021, 21: 1365-1375. PMID: 33251712, PMCID: PMC8016716, DOI: 10.1111/ajt.16397.
• Bile Microbiota in Liver Transplantation: Proof of Concept Using Gene Amplification in a Heterogeneous Clinical ScenarioD'Amico F, Bertacco A, Finotti M, Di Renzo C, Rodriguez-Davalos MI, Gondolesi GE, Cillo U, Mulligan D, Geibel J. Bile Microbiota in Liver Transplantation: Proof of Concept Using Gene Amplification in a Heterogeneous Clinical Scenario. Frontiers In Surgery 2021, 8: 621525. PMID: 33796547, PMCID: PMC8009296, DOI: 10.3389/fsurg.2021.621525.
• Changes in Use of Left Ventricular Assist Devices as Bridge to Transplantation With New Heart Allocation PolicyMullan CW, Chouairi F, Sen S, Mori M, Clark KAA, Reinhardt SW, Miller PE, Fuery MA, Jacoby D, Maulion C, Anwer M, Geirsson A, Mulligan D, Formica R, Rogers JG, Desai NR, Ahmad T. Changes in Use of Left Ventricular Assist Devices as Bridge to Transplantation With New Heart Allocation Policy. JACC Heart Failure 2021, 9: 420-429. PMID: 33714748, DOI: 10.1016/j.jchf.2021.01.010.
• Impact of the new heart allocation policy on patients with restrictive, hypertrophic, or congenital cardiomyopathiesChouairi F, Mullan CW, Sen S, Mori M, Fuery M, Elder RW, Lesse J, Norton K, Clark KA, Miller PE, Mulligan D, Formica R, Rogers JG, Jacoby D, Maulion C, Anwer M, Geirsson A, Desai NR, Ahmad T. Impact of the new heart allocation policy on patients with restrictive, hypertrophic, or congenital cardiomyopathies. PLOS ONE 2021, 16: e0247789. PMID: 33651802, PMCID: PMC7924739, DOI: 10.1371/journal.pone.0247789.
• Current status: meeting the regulatory goals of your liver transplant program.Batra RK, Mulligan DC. Current status: meeting the regulatory goals of your liver transplant program. Current Opinion In Organ Transplantation 2021, 26: 146-151. PMID: 33650996, DOI: 10.1097/mot.0000000000000869.
• Deep learning–assisted differentiation of pathologically proven atypical and typical hepatocellular carcinoma (HCC) versus non-HCC on contrast-enhanced MRI of the liverOestmann PM, Wang CJ, Savic LJ, Hamm CA, Stark S, Schobert I, Gebauer B, Schlachter T, Lin M, Weinreb JC, Batra R, Mulligan D, Zhang X, Duncan JS, Chapiro J. Deep learning–assisted differentiation of pathologically proven atypical and typical hepatocellular carcinoma (HCC) versus non-HCC on contrast-enhanced MRI of the liver. European Radiology 2021, 31: 4981-4990. PMID: 33409782, PMCID: PMC8222094, DOI: 10.1007/s00330-020-07559-1.
• The Impact of COVID‐19 on Organ Donation, Procurement, and Liver Transplantation in the United StatesMerola J, Schilsky ML, Mulligan DC. The Impact of COVID‐19 on Organ Donation, Procurement, and Liver Transplantation in the United States. Hepatology Communications 2021, 5: 5-11. PMID: 33043228, PMCID: PMC7537114, DOI: 10.1002/hep4.1620.
• Penicillin G Induces H+, K+-ATPase via a Nitric Oxide-Dependent Mechanism in the Rat Colonic CryptBaratta VM, Norz V, Barahona MJ, Gisinger TM, Mulligan D, Geibel JP. Penicillin G Induces H+, K+-ATPase via a Nitric Oxide-Dependent Mechanism in the Rat Colonic Crypt. Cellular Physiology And Biochemistry 2020, 54: 1132-1142. PMID: 33175479, PMCID: PMC8095381, DOI: 10.33594/000000305.
• The Development of a Comprehensive Multi-Institutional, Multi-Disciplinary Infrastructure for the Successful Implementation of a Robotic-Assisted Kidney Transplant (RAKT) ProgramHaakinson D, Tzvetanov I, Turner A, Deshpande R, Formica R, Kulkarni S, Benedetti E, Mulligan D. The Development of a Comprehensive Multi-Institutional, Multi-Disciplinary Infrastructure for the Successful Implementation of a Robotic-Assisted Kidney Transplant (RAKT) Program. Journal Of The American College Of Surgeons 2020, 231: e224. DOI: 10.1016/j.jamcollsurg.2020.08.597.
• INACTIVE STATUS CHANGE IS AN INDEPENDENT PREDICTOR OF WAITLIST MORTALITY AND DISPROPORTIONATELY IMPACTS PATIENTS IN DONOR SERVICE AREAS WITH A HIGHER MEDIAN MELD AT TRANSPLANTBatra R, Noreen S, Stewart D, Haakinson D, Gan G, Deng Y, Mulligan D, Kulkarni S. INACTIVE STATUS CHANGE IS AN INDEPENDENT PREDICTOR OF WAITLIST MORTALITY AND DISPROPORTIONATELY IMPACTS PATIENTS IN DONOR SERVICE AREAS WITH A HIGHER MEDIAN MELD AT TRANSPLANT. Transplantation 2020, 104: s213-s213. DOI: 10.1097/01.tp.0000699484.39814.91.
• Human Small Intestine Transplantation: Segmental Susceptibility to Ischemia Using Different Preservation Solutions and ConditionsLysyy T, Finotti M, Maina RM, Morotti R, Munoz-Abraham AS, Bertacco A, Ibarra C, Barahona M, Agarwal R, D'Amico F, Rodriguez-Davalos MI, Mulligan D, Geibel J. Human Small Intestine Transplantation: Segmental Susceptibility to Ischemia Using Different Preservation Solutions and Conditions. Transplantation Proceedings 2020, 52: 2934-2940. PMID: 32768284, DOI: 10.1016/j.transproceed.2020.06.031.
• Lysis of cold‐storage‐induced microvascular obstructions for ex vivo revitalization of marginal human kidneysDiRito JR, Hosgood SA, Reschke M, Albert C, Bracaglia LG, Ferdinand JR, Stewart BJ, Edwards CM, Vaish AG, Thiru S, Mulligan DC, Haakinson DJ, Clatworthy MR, Saltzman WM, Pober JS, Nicholson ML, Tietjen GT. Lysis of cold‐storage‐induced microvascular obstructions for ex vivo revitalization of marginal human kidneys. American Journal Of Transplantation 2020, 21: 161-173. PMID: 32627324, PMCID: PMC7775334, DOI: 10.1111/ajt.16148.
• Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID‐19 Pandemic: AASLD Expert Panel Consensus StatementFix OK, Hameed B, Fontana RJ, Kwok RM, McGuire BM, Mulligan DC, Pratt DS, Russo MW, Schilsky ML, Verna EC, Loomba R, Cohen DE, Bezerra JA, Reddy KR, Chung RT. Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID‐19 Pandemic: AASLD Expert Panel Consensus Statement. Hepatology 2020, 72: 287-304. PMID: 32298473, PMCID: PMC7262242, DOI: 10.1002/hep.31281.
• Fibronodular hepatocellular carcinoma—a new variant of liver cancer: clinical, pathological and radiological correlationTefera J, Revzin M, Chapiro J, Savic L, Mulligan D, Batra R, Taddei T, Jain D, Zhang X. Fibronodular hepatocellular carcinoma—a new variant of liver cancer: clinical, pathological and radiological correlation. Journal Of Clinical Pathology 2020, 74: 31-35. PMID: 32430483, PMCID: PMC7674234, DOI: 10.1136/jclinpath-2020-206574.
• Deceased donors: Defining drug‐related deathsCmunt K, Danovitch G, Delmonico F, Fynn‐Thompson F, Glazier A, Grandas J, Gunderson S, Jendrisak M, Johnson HK, Kulkarni S, Lipkowitz G, Meyer K, Mulligan D, Nathan H, Mone T, Moritz M, O'Connor K, Payne W, Souter M, Wood RP. Deceased donors: Defining drug‐related deaths. Clinical Transplantation 2020, 34: e13800. PMID: 32077534, DOI: 10.1111/ctr.13800.
• Salvage after Retroperitoneal Kidney Allograft TorsionGreco JM, Mulligan DC, Yoo PS. Salvage after Retroperitoneal Kidney Allograft Torsion. Case Reports In Transplantation 2020, 2020: 8024598. PMID: 32455047, PMCID: PMC7201506, DOI: 10.1155/2020/8024598.
• Frequency of whole-organ in lieu of split-liver transplantation over the last decade: Children experienced increased wait time and deathValentino PL, Emre S, Geliang G, Li L, Deng Y, Mulligan D, Rodriguez-Davalos M. Frequency of whole-organ in lieu of split-liver transplantation over the last decade: Children experienced increased wait time and death. American Journal Of Transplantation 2019, 19: 3114-3123. PMID: 31152483, DOI: 10.1111/ajt.15481.
• Portopulmonary Hypertension: A Survey of Practice Patterns and Provider AttitudesDuBrock HM, Salgia RJ, Sussman NL, Bartolome SD, Kadry Z, Mulligan DC, Jenkins S, Lackore K, Channick RN, Kawut SM, Krowka MJ. Portopulmonary Hypertension: A Survey of Practice Patterns and Provider Attitudes. Transplantation Direct 2019, 5: e456. PMID: 31321292, PMCID: PMC6553621, DOI: 10.1097/txd.0000000000000900.
• Activation of the Calcium Sensing Receptor Decreases Secretagogue-Induced Fluid Secretion in the Rat Small IntestineBarahona MJ, Maina RM, Lysyy T, Finotti M, Caturegli G, Baratta V, D’Amico F, Mulligan D, Geibel JP. Activation of the Calcium Sensing Receptor Decreases Secretagogue-Induced Fluid Secretion in the Rat Small Intestine. Frontiers In Physiology 2019, 10: 439. PMID: 31130866, PMCID: PMC6509940, DOI: 10.3389/fphys.2019.00439.
• Sa1746 – Oral Calcium Nanoparticle Therapy Aids in the Recovery from Dss-Induced Ulcerative Colitis in the Rat ModelBaratta V, Barahona M, Mulligan D, Geibel J. Sa1746 – Oral Calcium Nanoparticle Therapy Aids in the Recovery from Dss-Induced Ulcerative Colitis in the Rat Model. Gastroenterology 2019, 156: s-384-s-385. DOI: 10.1016/s0016-5085(19)37813-8.
• Sa1745 – Glacial Acetic Acid-Induced Ulcerative Colitis Lesions Improve After Oral Calcium Nanoparticle Therapy in a Rat ModelBarahona M, Baratta V, Mulligan D, Geibel J. Sa1745 – Glacial Acetic Acid-Induced Ulcerative Colitis Lesions Improve After Oral Calcium Nanoparticle Therapy in a Rat Model. Gastroenterology 2019, 156: s-384. DOI: 10.1016/s0016-5085(19)37812-6.
• Mo1102 – Aspirin and Ischemia in the Murine Distal ColonBaratta V, Barahona M, Mulligan D, Geibel J. Mo1102 – Aspirin and Ischemia in the Murine Distal Colon. Gastroenterology 2019, 156: s-708. DOI: 10.1016/s0016-5085(19)38700-1.
• Design and implementation of novel nutraceuticals and derivatives for treating intestinal disordersBarahona MJ, Baratta V, Ollodart J, Mulligan D, Geibel JP. Design and implementation of novel nutraceuticals and derivatives for treating intestinal disorders. Future Medicinal Chemistry 2019, 11: 847-855. PMID: 30994367, PMCID: PMC8008207, DOI: 10.4155/fmc-2018-0313.
• Building Local Communities of Prior Living Donors and Creating a Social Architecture to Improve Rates of Living Kidney DonationKulkarni S, Yoo P, Batra R, Haakinson D, Schulam P, Mulligan D. Building Local Communities of Prior Living Donors and Creating a Social Architecture to Improve Rates of Living Kidney Donation. Journal Of The American College Of Surgeons 2018, 227: e29. DOI: 10.1016/j.jamcollsurg.2018.08.074.
• American Society for Reproductive Medicine position statement on uterus transplantation: a committee opinionAllyse M, Amer H, Coutifaris C, Falcone T, Famuyide A, Flyckt R, Gargiulo A, Heimbach J, Johannesson L, Jowsey-Gregoire S, Khan Z, Langstraat C, Levin S, McDiarmid S, Miller C, Mulligan D, O'Neill K, Penzias A, Pfeifer S, Porrett P, Quintini C, Reindollar R, Rosen C, Silasi D, Stewart E, Testa G, Tzakis A, Tullius S, Penzias A, Bendikson K, Falcone T, Gitlin S, Gracia C, Hansen K, Jindal S, Kalra S, Mersereau J, Odem R, Rebar R, Reindollar R, Rosen M, Sandlow J, Schlegel P, Stovall D. American Society for Reproductive Medicine position statement on uterus transplantation: a committee opinion. Fertility And Sterility 2018, 110: 605-610. PMID: 30196945, DOI: 10.1016/j.fertnstert.2018.06.017.
• Successful treatment of primary donor‐derived human herpesvirus‐8 infection and hepatic Kaposi Sarcoma in an adult liver transplant recipientFu W, Merola J, Malinis M, Lacy J, Barbieri A, Liapakis AH, Mulligan DC, Yoo PS. Successful treatment of primary donor‐derived human herpesvirus‐8 infection and hepatic Kaposi Sarcoma in an adult liver transplant recipient. Transplant Infectious Disease 2018, 20: e12966. PMID: 30014622, DOI: 10.1111/tid.12966.
• Prevention of Ischemic Injury in Colon and Small Intestine in an Ex Vivo Perfusion Animal ModelFinotti M, Lysyy T, Barahona M, Maina R, Caturegli G, D'Amico F, Mulligan D, Geibel J. Prevention of Ischemic Injury in Colon and Small Intestine in an Ex Vivo Perfusion Animal Model. Transplantation 2018, 102: s709. DOI: 10.1097/01.tp.0000543675.85457.d2.
• Activation of the Calcium Sensing Receptor (casr) Prevents Secretagogue-Induced Diarrhea in the Rat Small IntestineFinotti M, Lysyy T, Caturegli G, Barahona M, Maina R, D'Amico F, Mulligan D, Geibel J. Activation of the Calcium Sensing Receptor (casr) Prevents Secretagogue-Induced Diarrhea in the Rat Small Intestine. Transplantation 2018, 102: s669. DOI: 10.1097/01.tp.0000543607.00911.f4.
• Generating vascular conduits: from tissue engineering to three-dimensional bioprintingMaina RM, Barahona MJ, Finotti M, Lysyy T, Geibel P, D’Amico F, Mulligan D, Geibel JP. Generating vascular conduits: from tissue engineering to three-dimensional bioprinting. Innovative Surgical Sciences 2018, 3: 203-213. PMID: 31579784, PMCID: PMC6604577, DOI: 10.1515/iss-2018-0016.
• Trends and the Current Status of Living Donor Liver TransplantBatra R, Mulligan D. Trends and the Current Status of Living Donor Liver Transplant. 2018 DOI: 10.5772/intechopen.74818.
• Sa1180 - Activation of the Calcium Sensing Receptor (Casr) Leads to Enhanced Fluid and Electrolyte Absorption in the Rat Small IntestineLysyy T, Caturegli G, Finotti M, Maina R, Barahona M, D'Amico F, Mulligan D, Geibel J. Sa1180 - Activation of the Calcium Sensing Receptor (Casr) Leads to Enhanced Fluid and Electrolyte Absorption in the Rat Small Intestine. Gastroenterology 2018, 154: s-269-s-270. DOI: 10.1016/s0016-5085(18)31261-7.
• Robotic Assisted Kidney Transplant, Reserved for the DeservedBatra R, Mulligan D, Kulkarni S, Bhati C. Robotic Assisted Kidney Transplant, Reserved for the Deserved. Journal Of Clinical And Experimental Transplantation 2018, 3: 1-3. DOI: 10.4172/2475-7640.1000e104.
• Modulation of Intestinal Microbiome Prevents Intestinal Ischemic InjuryBertacco A, Dehner CA, Caturegli G, D'Amico F, Morotti R, Rodriguez MI, Mulligan DC, Kriegel MA, Geibel JP. Modulation of Intestinal Microbiome Prevents Intestinal Ischemic Injury. Frontiers In Physiology 2017, 8: 1064. PMID: 29311987, PMCID: PMC5742259, DOI: 10.3389/fphys.2017.01064.
• Predictors of Waitlist Mortality in Portopulmonary HypertensionDuBrock HM, Goldberg DS, Sussman NL, Bartolome SD, Kadry Z, Salgia RJ, Mulligan DC, Kremers WK, Kawut SM, Krowka MJ, Channick RN. Predictors of Waitlist Mortality in Portopulmonary Hypertension. Transplantation 2017, 101: 1609-1615. PMID: 28207639, PMCID: PMC5481480, DOI: 10.1097/tp.0000000000001666.
• Allograft transmission of hepatitis C during the window period: Weighing the new risks and costs in the era of donor shortageChoe J, Merola J, Kulkarni S, Mulligan DC. Allograft transmission of hepatitis C during the window period: Weighing the new risks and costs in the era of donor shortage. Clinical Transplantation 2017, 31 PMID: 28643333, DOI: 10.1111/ctr.13022.
• Liver retransplantation: Recurrent primary sclerosing cholangitis may provide better outcomesChoe J, Mulligan DC. Liver retransplantation: Recurrent primary sclerosing cholangitis may provide better outcomes. Liver Transplantation 2017, 23: 730-732. PMID: 28425147, DOI: 10.1002/lt.24777.
• Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver diseaseNadim MK, DiNorcia J, Ji L, Groshen S, Levitsky J, Sung RS, Kim WR, Andreoni K, Mulligan D, Genyk YS. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease. Journal Of Hepatology 2017, 67: 517-525. PMID: 28483678, PMCID: PMC7735955, DOI: 10.1016/j.jhep.2017.04.022.
• Sa1982 Elevated no Production is Protective Against Small Intestine Ischemic InjuryIbarra C, Caturegli G, Abraham A, Rodriguez-Davalos M, Mulligan D, Geibel J. Sa1982 Elevated no Production is Protective Against Small Intestine Ischemic Injury. Gastroenterology 2017, 152: s415-s416. DOI: 10.1016/s0016-5085(17)31617-7.
• Liver allocation and distributionDeshpande R, Hirose R, Mulligan D. Liver allocation and distribution. Current Opinion In Organ Transplantation 2017, 22: 162-168. PMID: 28212159, DOI: 10.1097/mot.0000000000000397.
• 3D Bioprinting in TransplantationMunoz-Abraham A, Ibarra C, Agarwal R, Geibel J, Mulligan D. 3D Bioprinting in Transplantation. 2017, 261-276. DOI: 10.1007/978-3-319-62142-5_11.
• Changes in united network for organ sharing policy for simultaneous liver‐kidney allocationMerola J, Formica RN, Mulligan DC. Changes in united network for organ sharing policy for simultaneous liver‐kidney allocation. Clinical Liver Disease 2017, 9: 21-24. PMID: 30992951, PMCID: PMC6467132, DOI: 10.1002/cld.609.
• The ongoing quest to find the appropriate patients to transplant with hepatocellular carcinoma: Milan to san Francisco to Toronto and beyondMulligan D. The ongoing quest to find the appropriate patients to transplant with hepatocellular carcinoma: Milan to san Francisco to Toronto and beyond. Hepatology 2016, 64: 1853-1855. PMID: 27641833, DOI: 10.1002/hep.28841.
• Belatacept and Eculizumab for Treatment of Calcineurin Inhibitor-induced Thrombotic Microangiopathy After Kidney Transplantation: Case ReportMerola J, Yoo PS, Schaub J, Smith JD, Rodriguez-Davalos MI, Tichy E, Mulligan DC, Asch W, Formica R, Kashgarian M, Kulkarni S. Belatacept and Eculizumab for Treatment of Calcineurin Inhibitor-induced Thrombotic Microangiopathy After Kidney Transplantation: Case Report. Transplantation Proceedings 2016, 48: 3106-3108. PMID: 27932157, DOI: 10.1016/j.transproceed.2016.04.005.
• A resilience intervention involving mindfulness training for transplant patients and their caregiversStonnington CM, Darby B, Santucci A, Mulligan P, Pathuis P, Cuc A, Hentz JG, Zhang N, Mulligan D, Sood A. A resilience intervention involving mindfulness training for transplant patients and their caregivers. Clinical Transplantation 2016, 30: 1466-1472. PMID: 27618687, DOI: 10.1111/ctr.12841.
• Risks and Epidemiology of Infections After Liver TransplantationPatron R, Kusne S, Mulligan D. Risks and Epidemiology of Infections After Liver Transplantation. 2016, 215-233. DOI: 10.1007/978-3-319-28797-3_14.
• Is Normothermic Perfusion a Feasible Option for Intestinal Preservation? Experience with a Porcine ModelBertacco A, AlKukhun A, Kitay A, Aldajani M, D'Amico F, Rodriguez-Davalos M, Mulligan D, Geibel J. Is Normothermic Perfusion a Feasible Option for Intestinal Preservation? Experience with a Porcine Model. Journal Of The American College Of Surgeons 2016, 223: e50-e51. DOI: 10.1016/j.jamcollsurg.2016.08.147.
• Use of FITC-Inulin As a Real-Time Marker For Intestinal Graft ViabilityAlKukhun A, Bertacco A, Abraham A, Caturegli G, D'Amico F, Rodriguez-Davalos M, Mulligan D, Geibel J. Use of FITC-Inulin As a Real-Time Marker For Intestinal Graft Viability. Journal Of The American College Of Surgeons 2016, 223: e193. DOI: 10.1016/j.jamcollsurg.2016.08.489.
• Predicting Outcomes on the Liver Transplant Waiting List in the United StatesHart A, Schladt DP, Zeglin J, Pyke J, Kim WR, Lake JR, Roberts JP, Hirose R, Mulligan DC, Kasiske BL, Snyder JJ, Israni AK. Predicting Outcomes on the Liver Transplant Waiting List in the United States. Transplantation 2016, 100: 2153-2159. PMID: 27490411, PMCID: PMC5369025, DOI: 10.1097/tp.0000000000001384.
• Resolving Misconceptions About Liver Allocation and Redistricting MethodologyGentry SE, Hirose R, Mulligan D. Resolving Misconceptions About Liver Allocation and Redistricting Methodology. JAMA Surgery 2016, 151: 991-992. PMID: 27333440, DOI: 10.1001/jamasurg.2016.1315.
• Partners in Crime: Kidney Transplantation and Seizure DisorderLi N, Jean R, Tooley JE, Mulligan DC, Yoo PS. Partners in Crime: Kidney Transplantation and Seizure Disorder. Transplantation Proceedings 2016, 48: 2700-2708. PMID: 27788804, DOI: 10.1016/j.transproceed.2016.06.041.
• Attitudes toward organ donation among waitlisted transplant patients: results of a cross‐sectional surveyMerola J, Pei K, Rodriguez‐Davalos M, Gan G, Deng Y, Mulligan DC, Davis KA. Attitudes toward organ donation among waitlisted transplant patients: results of a cross‐sectional survey. Clinical Transplantation 2016, 30: 1449-1456. PMID: 27582432, PMCID: PMC5093046, DOI: 10.1111/ctr.12839.
• Perioperative outcomes of coronary artery bypass graft in renal transplant recipients in the United States: results from the Nationwide Inpatient SampleTooley JE, Bohl DD, Kulkarni S, Rodriguez‐Davalos M, Mangi A, Mulligan DC, Yoo PS. Perioperative outcomes of coronary artery bypass graft in renal transplant recipients in the United States: results from the Nationwide Inpatient Sample. Clinical Transplantation 2016, 30: 1258-1263. PMID: 27440000, DOI: 10.1111/ctr.12816.
• The Long‐Term Follow‐up and Support for Living Organ Donors: A Center‐Based Initiative Founded on Developing a Community of Living DonorsKulkarni S, Thiessen C, Formica RN, Schilsky M, Mulligan D, D'Aquila R. The Long‐Term Follow‐up and Support for Living Organ Donors: A Center‐Based Initiative Founded on Developing a Community of Living Donors. American Journal Of Transplantation 2016, 16: 3385-3391. PMID: 27500361, DOI: 10.1111/ajt.14005.
• Postoperative delirium is associated with increased intensive care unit and hospital length of stays after liver transplantationBhattacharya B, Maung A, Barre K, Maerz L, Rodriguez-Davalos MI, Schilsky M, Mulligan DC, Davis KA. Postoperative delirium is associated with increased intensive care unit and hospital length of stays after liver transplantation. Journal Of Surgical Research 2016, 207: 223-228. PMID: 27979481, DOI: 10.1016/j.jss.2016.08.084.
• What Every Hepatologist Should Know about Liver TransplantationYoo P, Mulligan D. What Every Hepatologist Should Know about Liver Transplantation. 2016, 608-616. DOI: 10.1002/9781119127437.ch93.
• De Novo Belatacept in a Human Immunodeficiency Virus–Positive Kidney Transplant RecipientCohen E, Mulligan D, Kulkarni S, Tichy E. De Novo Belatacept in a Human Immunodeficiency Virus–Positive Kidney Transplant Recipient. American Journal Of Transplantation 2016, 16: 2753-2757. PMID: 27137752, DOI: 10.1111/ajt.13852.
• Corrigendum to “Management of the critically ill patients with cirrhosis: A multidisciplinary perspective”Nadim MK, Durand F, Kellum JA, Levitsky J, O’Leary J, Karvellas CJ, Bajaj JS, Davenport A, Jalan R, Angeli P, Caldwell SH, Fernández J, Francoz C, Garcia-Tsao G, Ginès P, Ison MG, Kramer DJ, Mehta RL, Moreau R, Mulligan D, Olson JC, Pomfret EA, Senzolo M, Steadman RH, Subramanian RM, Vincent JL, Genyk YS. Corrigendum to “Management of the critically ill patients with cirrhosis: A multidisciplinary perspective”. Journal Of Hepatology 2016, 65: 452. PMID: 27241199, DOI: 10.1016/j.jhep.2016.05.001.
• The impact of broader regional sharing of livers: 2‐year results of “Share 35”Edwards EB, Harper AM, Hirose R, Mulligan DC. The impact of broader regional sharing of livers: 2‐year results of “Share 35”. Liver Transplantation 2016, 22: 399-409. PMID: 26890858, DOI: 10.1002/lt.24418.
• 3D Printing of Organs for Transplantation: Where Are We and Where Are We Heading?Munoz-Abraham A, Rodriguez-Davalos M, Bertacco A, Wengerter B, Geibel J, Mulligan D. 3D Printing of Organs for Transplantation: Where Are We and Where Are We Heading? Current Transplantation Reports 2016, 3: 93-99. DOI: 10.1007/s40472-016-0089-6.
• Extracorporeal Hypothermic Perfusion Device for Intestinal Graft Preservation to Decrease Ischemic Injury During TransportationMuñoz-Abraham AS, Patrón-Lozano R, Narayan RR, Judeeba SS, Alkukhun A, Alfadda TI, Belter JT, Mulligan DC, Morotti R, Zinter JP, Geibel JP, Rodríguez-Dávalos MI. Extracorporeal Hypothermic Perfusion Device for Intestinal Graft Preservation to Decrease Ischemic Injury During Transportation. Journal Of Gastrointestinal Surgery 2016, 20: 313-321. PMID: 26487331, DOI: 10.1007/s11605-015-2986-x.
• Simultaneous Liver–Kidney Allocation Policy: A Proposal to Optimize Appropriate Utilization of Scarce ResourcesFormica R, Aeder M, Boyle G, Kucheryavaya A, Stewart D, Hirose R, Mulligan D. Simultaneous Liver–Kidney Allocation Policy: A Proposal to Optimize Appropriate Utilization of Scarce Resources. American Journal Of Transplantation 2016, 16: 758-766. PMID: 26603142, DOI: 10.1111/ajt.13631.
• Increasing the Number of Organs Available to Transplant Is Separate From Ensuring Equitable Distribution of Available Organs: Both Are Important GoalsHirose R, Gentry SE, Mulligan DC. Increasing the Number of Organs Available to Transplant Is Separate From Ensuring Equitable Distribution of Available Organs: Both Are Important Goals. American Journal Of Transplantation 2016, 16: 728-729. PMID: 26757240, DOI: 10.1111/ajt.13577.
• Management of the critically ill patient with cirrhosis: A multidisciplinary perspectiveNadim MK, Durand F, Kellum JA, Levitsky J, O’Leary J, Karvellas CJ, Bajaj JS, Davenport A, Jalan R, Angeli P, Caldwell SH, Fernández J, Francoz C, Garcia-Tsao G, Ginès P, Ison MG, Kramer DJ, Mehta RL, Moreau R, Mulligan D, Olson JC, Pomfret EA, Senzolo M, Steadman RH, Subramanian RM, Vincent JL, Genyk YS. Management of the critically ill patient with cirrhosis: A multidisciplinary perspective. Journal Of Hepatology 2015, 64: 717-735. PMID: 26519602, DOI: 10.1016/j.jhep.2015.10.019.
• Robust Models Support Redistricting Liver Allocation to Reduce Geographic DisparityGentry SE, Segev DL, Kasiske BL, Mulligan DC, Hirose R. Robust Models Support Redistricting Liver Allocation to Reduce Geographic Disparity. Transplantation 2015, 99: e159-e160. PMID: 26308421, PMCID: PMC4576715, DOI: 10.1097/tp.0000000000000834.
• Non‐alcoholic fatty liver disease following liver transplantation: a clinical reviewMerola J, Liapakis A, Mulligan DC, Yoo PS. Non‐alcoholic fatty liver disease following liver transplantation: a clinical review. Clinical Transplantation 2015, 29: 728-737. PMID: 26147308, DOI: 10.1111/ctr.12585.
• Disparity, Liver Demand, and Access to TransplantsMulligan D. Disparity, Liver Demand, and Access to Transplants. American Journal Of Transplantation 2015, 15: 1746-1747. PMID: 25929170, DOI: 10.1111/ajt.13302.
• Tu1044 Sofosbuvir-Based Interferon-Free Regimens for Hepatitis C Infection in Patients With Compensated and Decompensated Cirrhosis: Interim Analysis of a Prospective Observational CohortDo A, Lim J, Liapakis A, Babas G, Caldwell C, Fortune B, Emre S, Kulkarni S, Lempit S, Mistry P, Mulligan D, Rodriguez-Davalos M, Schilsky M, Tichy E, Yoo P, Jakab S. Tu1044 Sofosbuvir-Based Interferon-Free Regimens for Hepatitis C Infection in Patients With Compensated and Decompensated Cirrhosis: Interim Analysis of a Prospective Observational Cohort. Gastroenterology 2015, 148: s-1094-s-1095. DOI: 10.1016/s0016-5085(15)33733-1.
• Early Changes in Liver Distribution Following Implementation of Share 35Massie AB, Chow EK, Wickliffe CE, Luo X, Gentry SE, Mulligan DC, Segev DL. Early Changes in Liver Distribution Following Implementation of Share 35. American Journal Of Transplantation 2015, 15: 659-667. PMID: 25693474, PMCID: PMC6116537, DOI: 10.1111/ajt.13099.
• Liver allocation: Can we ever get it right and should we ever get it right?Neuberger J, Mulligan D. Liver allocation: Can we ever get it right and should we ever get it right? Hepatology 2015, 61: 28-31. PMID: 25130673, DOI: 10.1002/hep.27359.
• Magnetic resonance elastography can discriminate normal vs. abnormal liver biopsy in candidates for live liver donationGallegos-Orozco JF, Silva AC, Batheja MJ, Chang YH, Hansen KL, Lam-Himlin D, De Petris G, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan DC, Silva AM, Rakela J, Vargas HE. Magnetic resonance elastography can discriminate normal vs. abnormal liver biopsy in candidates for live liver donation. Abdominal Radiology 2014, 40: 795-802. PMID: 25445158, DOI: 10.1007/s00261-014-0310-y.
• Straddling The Fence With Middle Hepatic Vein For Living Liver Donors.Batra R, Mulligan D, Reddy S, Hewitt W, Katariya N, Douglas D, Moss A. Straddling The Fence With Middle Hepatic Vein For Living Liver Donors. Transplantation 2014, 98: 784. DOI: 10.1097/00007890-201407151-02685.
• Donor-Derived West Nile Virus Infection in Solid Organ Transplant RecipientsWinston DJ, Vikram HR, Rabe IB, Dhillon G, Mulligan D, Hong JC, Busuttil RW, Nowicki MJ, Mone T, Civen R, Tecle SA, Trivedi KK, Hocevar SN. Donor-Derived West Nile Virus Infection in Solid Organ Transplant Recipients. Transplantation 2014, 97: 881-889. PMID: 24827763, PMCID: PMC5765745, DOI: 10.1097/tp.0000000000000024.
• 758 When Tissue Is the Issue: A New Device for Extracorporeal Hypothermic Perfusion of Intestinal Lumen and Vasculature Decreases the Rate of Necrosis During Graft TransportationNarayan R, Patron-Lozano R, Loeb B, Oki K, Pancer N, Crouch A, Chauhan Y, Backus S, Fan R, Zinter J, Mulligan D, Emre S, Geibel J, Rodriguez-Davalos M. 758 When Tissue Is the Issue: A New Device for Extracorporeal Hypothermic Perfusion of Intestinal Lumen and Vasculature Decreases the Rate of Necrosis During Graft Transportation. Gastroenterology 2014, 146: s-1029-s-1030. DOI: 10.1016/s0016-5085(14)63753-7.
• Written informed consent for living liver donor evaluation: Compliance with centers for medicare and medicaid services and organ procurement and transplantation network guidelines and alibi offersThiessen C, Kim YA, Yoo PS, Rodriguez‐Davalos M, Mulligan D, Kulkarni S. Written informed consent for living liver donor evaluation: Compliance with centers for medicare and medicaid services and organ procurement and transplantation network guidelines and alibi offers. Liver Transplantation 2014, 20: 416-424. PMID: 24415564, DOI: 10.1002/lt.23822.
• Preoperative chemoradiation and IOERT for unresectable or borderline resectable pancreas cancerAshman JB, Moss AA, Rule WG, Callister MG, Reddy KS, Mulligan DC, Collins JM, De Petris G, Gunderson LL, Borad M. Preoperative chemoradiation and IOERT for unresectable or borderline resectable pancreas cancer. Journal Of Gastrointestinal Oncology 2013, 4: 352-60. PMID: 24294506, PMCID: PMC3819779, DOI: 10.3978/j.issn.2078-6891.2013.006.
• New Onset Diabetes Mellitus in Living Donor versus Deceased Donor Liver Transplant Recipients: Analysis of the UNOS/OPTN DatabaseYadav AD, Chang YH, Aqel BA, Byrne TJ, Chakkera HA, Douglas DD, Mulligan DC, Rakela J, Vargas HE, Carey EJ. New Onset Diabetes Mellitus in Living Donor versus Deceased Donor Liver Transplant Recipients: Analysis of the UNOS/OPTN Database. Journal Of Transplantation 2013, 2013: 269096. PMID: 24205434, PMCID: PMC3800575, DOI: 10.1155/2013/269096.
• Successful Abdominal Organ Donation after Brain Death in a Patient with a Biventricular Assist Device: Extending Extended CriteriaCarpenter S, Steidley D, Douglas D, Reddy K, Mulligan D, Lanza L, Moss A. Successful Abdominal Organ Donation after Brain Death in a Patient with a Biventricular Assist Device: Extending Extended Criteria. Open Journal Of Organ Transplant Surgery 2013, 2013: 32-35. DOI: 10.4236/ojots.2013.32006.
• Genetic Differences in Native Americans and Tacrolimus Dosing After Kidney TransplantationChakkera HA, Chang Y, Bodner JK, Behmen S, Heilman RL, Reddy KS, Mulligan DC, Moss AA, Khamash H, Katariya N, Hewitt WR, Pitta TL, Frassetto LA. Genetic Differences in Native Americans and Tacrolimus Dosing After Kidney Transplantation. Transplantation Proceedings 2013, 45: 137-141. PMID: 23375287, DOI: 10.1016/j.transproceed.2012.10.023.
• Robotic resection of choledochocele in an adult with intracorporeal hepaticojejunostomy and Roux-en-Y anastomosis: encouraging progress for robotic surgical treatment of biliary diseaseCarpenter SG, Grimsby G, DeMasters T, Katariya N, Hewitt WR, Moss AA, Reddy KS, Castle EP, Mulligan DC. Robotic resection of choledochocele in an adult with intracorporeal hepaticojejunostomy and Roux-en-Y anastomosis: encouraging progress for robotic surgical treatment of biliary disease. Journal Of Robotic Surgery 2012, 8: 77-80. PMID: 27637243, DOI: 10.1007/s11701-012-0389-5.
• Baseline Biopsy Findings and Clinical Outcomes in Recipients of Kidneys from Standard Criteria Donors (SCD) with Acute Kidney Injury (AKI)Reddy K, Smith M, Chakkera H, Moss A, Mulligan D, Khamash H, Hewitt W, Katariya N, Heilman R. Baseline Biopsy Findings and Clinical Outcomes in Recipients of Kidneys from Standard Criteria Donors (SCD) with Acute Kidney Injury (AKI). Transplantation 2012, 94: 341. DOI: 10.1097/00007890-201211271-00631.
• Impact of Using Deceased Donor Kidneys with Acute Kidney Injury (AKI) on 1-Year Protocol Biopsy FindingsHeilman R, Smith M, Chakkera H, Khamash H, Hamawi K, Moss A, Katariya N, Mulligan D, Reddy K. Impact of Using Deceased Donor Kidneys with Acute Kidney Injury (AKI) on 1-Year Protocol Biopsy Findings. Transplantation 2012, 94: 243. DOI: 10.1097/00007890-201211271-00453.
• Single Center Review of Seroconversion Rate and Clinical Outcomes of Kidney Transplant Recipients from Center for Disease Control (CDC) High Risk DonorsBodner J, Katariya N, Hewitt W, Moss A, Mulligan D, Heilman R, Chakkera H, Hamawi K, Khamash H, Beck G, Reddy K. Single Center Review of Seroconversion Rate and Clinical Outcomes of Kidney Transplant Recipients from Center for Disease Control (CDC) High Risk Donors. Transplantation 2012, 94: 141. DOI: 10.1097/00007890-201211271-00260.
• Impact of Using Deceased Donor Kidneys with Acute Kidney Injury (AKI) on 1-Year Protocol Biopsy FindingsHeilman R, Smith M, Chakkera H, Khamash H, Hamawi K, Moss A, Katariya N, Mulligan D, Reddy K. Impact of Using Deceased Donor Kidneys with Acute Kidney Injury (AKI) on 1-Year Protocol Biopsy Findings. Transplantation 2012, 94: 1021. DOI: 10.1097/00007890-201211271-02021.
• Living donor safety during the performance of hepatectomyMulligan DC. Living donor safety during the performance of hepatectomy. Liver Transplantation 2012, 18: 1134-1135. PMID: 22821707, DOI: 10.1002/lt.23514.
• Endoscopic treatment of anastomotic biliary strictures after living donor liver transplantation: outcomes after maximal stent therapyHsieh TH, Mekeel KL, Crowell MD, Nguyen CC, Das A, Aqel BA, Carey EJ, Byrne TJ, Vargas HE, Douglas DD, Mulligan DC, Harrison ME. Endoscopic treatment of anastomotic biliary strictures after living donor liver transplantation: outcomes after maximal stent therapy. Gastrointestinal Endoscopy 2012, 77: 47-54. PMID: 23062758, DOI: 10.1016/j.gie.2012.08.034.
• Immune Mediated Hemolytic Anemia (IMHA) and Thrombocytopenia (ITP) in Liver Transplant RecipientsCostilla V, Aqel B, Byrne T, Douglas D, Vargas H, Mulligan D, Carey E. Immune Mediated Hemolytic Anemia (IMHA) and Thrombocytopenia (ITP) in Liver Transplant Recipients. The American Journal Of Gastroenterology 2012, 107: s150. DOI: 10.14309/00000434-201210001-00353.
• Laparoscopic bilateral native nephrectomies with simultaneous kidney transplantationMartin AD, Mekeel KL, Castle EP, Vaish SS, Martin GL, Moss AA, Mulligan DC, Heilman RL, Reddy KS, Andrews PE. Laparoscopic bilateral native nephrectomies with simultaneous kidney transplantation. BJU International 2012, 110: e1003-e1007. PMID: 22882539, DOI: 10.1111/j.1464-410x.2012.11379.x.
• Polyomavirus JC Urinary Shedding in Kidney and Liver Transplant Recipients Associated With Reduced Creatinine ClearanceKusne S, Vilchez RA, Zanwar P, Quiroz J, Mazur MJ, Heilman RL, Mulligan D, Butel JS. Polyomavirus JC Urinary Shedding in Kidney and Liver Transplant Recipients Associated With Reduced Creatinine Clearance. The Journal Of Infectious Diseases 2012, 206: 875-880. PMID: 22802433, PMCID: PMC3501156, DOI: 10.1093/infdis/jis469.
• A Consolidated Biovigilance System for Blood, Tissue and Organs: One Size Does Not Fit AllPruett TL, Blumberg EA, Cohen DJ, Crippin JS, Freeman RB, Hanto DW, Mulligan DC, Green MD. A Consolidated Biovigilance System for Blood, Tissue and Organs: One Size Does Not Fit All. American Journal Of Transplantation 2012, 12: 1099-1101. PMID: 22487495, DOI: 10.1111/j.1600-6143.2011.03907.x.
• 227 MAGNETIC RESONANCE ELASTOGRAPHY (MRE) CAN DISCRIMINATE NORMAL VS. ABNORMAL LIVER BIOPSY IN CANDIDATES FOR LIVE LIVER DONATIONGallegos-Orozco J, Silva A, Chang Y, Batheja M, Hansen K, Dora L, De Petris G, Carey E, Aqel B, Byrne T, Douglas D, Mulligan D, Rakela J, Silva A, Vargas H. 227 MAGNETIC RESONANCE ELASTOGRAPHY (MRE) CAN DISCRIMINATE NORMAL VS. ABNORMAL LIVER BIOPSY IN CANDIDATES FOR LIVE LIVER DONATION. Journal Of Hepatology 2012, 56: s96. DOI: 10.1016/s0168-8278(12)60240-2.
• Ureteral stricture formation in laparoscopically procured living donor kidney transplantation.Tyson MD, Castle EP, Andrews PE, Heilman RL, Moss AA, Mulligan DC, Reddy KS. Ureteral stricture formation in laparoscopically procured living donor kidney transplantation. Canadian Journal Of Urology 2012, 19: 6188-92. PMID: 22512964.
• Neoadjuvant chemoradiation and intraoperative electron irradiation for locally unresectable/borderline resectable pancreas adenocarcinoma.Ashman J, Moss A, Callister M, Reddy K, Mulligan D, Gunderson L, Borad M. Neoadjuvant chemoradiation and intraoperative electron irradiation for locally unresectable/borderline resectable pancreas adenocarcinoma. Journal Of Clinical Oncology 2012, 30: 327-327. DOI: 10.1200/jco.2012.30.4_suppl.327.
• Pretransplant Fasting Glucose Predicts New-Onset Diabetes after Liver TransplantationCarey EJ, Aqel BA, Byrne TJ, Douglas DD, Rakela J, Vargas HE, Moss AA, Mulligan DC, Reddy KS, Chakkera HA. Pretransplant Fasting Glucose Predicts New-Onset Diabetes after Liver Transplantation. Journal Of Transplantation 2012, 2012: 614781. PMID: 22461975, PMCID: PMC3306927, DOI: 10.1155/2012/614781.
• A randomized, multicenter study comparing steroid‐free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis CKlintmalm GB, Davis GL, Teperman L, Netto GJ, Washburn K, Rudich SM, Pomfret EA, Vargas HE, Brown R, Eckhoff D, Pruett TL, Roberts J, Mulligan DC, Charlton MR, Heffron TG, Ham JM, Douglas DD, Sher L, Baliga PK, Kinkhabwala M, Koneru B, Abecassis M, Millis M, Jennings LW, Fasola CG. A randomized, multicenter study comparing steroid‐free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C. Liver Transplantation 2011, 17: 1394-1403. PMID: 21850690, DOI: 10.1002/lt.22417.
• Resolution of Long-Standing Necrobiosis Lipoidica Diabeticorum (NLD) Lesion After Restoration of Euglycemia Following Successful Pancreas After Kidney (PAK) Transplantation: A Case ReportMazur M, Lowney A, Prigoff J, Heilman R, Chakkera H, Moss A, Mulligan D, Reddy K, Hamawi K. Resolution of Long-Standing Necrobiosis Lipoidica Diabeticorum (NLD) Lesion After Restoration of Euglycemia Following Successful Pancreas After Kidney (PAK) Transplantation: A Case Report. Transplantation Proceedings 2011, 43: 3296-3298. PMID: 22099781, DOI: 10.1016/j.transproceed.2011.10.005.
• Laparoscopic Distal PancreatectomyMekeel KL, Moss AA, Reddy KS, Mulligan DC, Harold KL. Laparoscopic Distal Pancreatectomy. Surgical Laparoscopy Endoscopy & Percutaneous Techniques 2011, 21: 362-365. PMID: 22002275, DOI: 10.1097/sle.0b013e31822e0ea8.
• Pretransplant Risk Score for New-Onset Diabetes After Kidney TransplantationChakkera HA, Weil EJ, Swanson CM, Dueck AC, Heilman RL, Reddy KS, Hamawi K, Khamash H, Moss AA, Mulligan DC, Katariya N, Knowler WC. Pretransplant Risk Score for New-Onset Diabetes After Kidney Transplantation. Diabetes Care 2011, 34: 2141-2145. PMID: 21949218, PMCID: PMC3177751, DOI: 10.2337/dc11-0752.
• Monoclonal Gammopathy of Undetermined Significance Does Not Affect Outcomes in Patients Undergoing Solid Organ TransplantsJimenez-Zepeda VH, Heilman RL, Engel RA, Carey EJ, Freeman C, Rakela J, Mulligan DC, Fonseca R, Stewart AK. Monoclonal Gammopathy of Undetermined Significance Does Not Affect Outcomes in Patients Undergoing Solid Organ Transplants. Transplantation 2011, 92: 570-574. PMID: 21712755, DOI: 10.1097/tp.0b013e318225db2c.
• When Disaster Strikes: Donor Deaths Are Treated With Intense Scrutiny, but Broader Sharing of Information to Benefit All Living Donors Should Be ImplementedMulligan D, Abecassis M, Johnson M. When Disaster Strikes: Donor Deaths Are Treated With Intense Scrutiny, but Broader Sharing of Information to Benefit All Living Donors Should Be Implemented. American Journal Of Transplantation 2011, 11: 1540-1541. PMID: 21672145, DOI: 10.1111/j.1600-6143.2011.03586.x.
• Living donor kidney transplantation with multiple renal arteries in the laparoscopic eraTyson, Castle E, Ko E, Andrews P, Heilman R, Mekeel K, Moss A, Mulligan D, Reddy K. Living donor kidney transplantation with multiple renal arteries in the laparoscopic era. International Braz J Urol 2011, 37: 401-402. DOI: 10.1590/s1677-55382011000300018.
• A Technique for Kidney Retransplantation After Simultaneous Kidney Pancreas TransplantationMekeel KL, Moss AA, Mulligan DC, Reddy KS. A Technique for Kidney Retransplantation After Simultaneous Kidney Pancreas Transplantation. Transplantation Proceedings 2011, 43: 1627-1628. PMID: 21693246, DOI: 10.1016/j.transproceed.2011.03.026.
• Impact of Acute Rejection on Kidney Allograft Outcomes in Recipients on Rapid Steroid WithdrawalHeilman RL, Nijim S, Chakkera HA, Devarapalli Y, Moss AA, Mulligan DC, Mazur MJ, Hamawi K, Williams JW, Reddy KS. Impact of Acute Rejection on Kidney Allograft Outcomes in Recipients on Rapid Steroid Withdrawal. Journal Of Transplantation 2011, 2011: 583981. PMID: 21647349, PMCID: PMC3103882, DOI: 10.1155/2011/583981.
• Mo1495 Anastomotic Biliary Strictures After Living Donor Liver Transplant: Ischemia Increases Recurrence Following Initial Endoscopic TreatmentHsieh T, Harrison M, Crowell M, Mekeel K, Aqel B, Carey E, Byrne T, Vargas H, Douglas D, Rakela J, Reddy K, Moss A, Mulligan D. Mo1495 Anastomotic Biliary Strictures After Living Donor Liver Transplant: Ischemia Increases Recurrence Following Initial Endoscopic Treatment. Gastrointestinal Endoscopy 2011, 73: ab363-ab364. DOI: 10.1016/j.gie.2011.03.793.
• Endoscopic Treatment of Anastomotic Biliary Strictures After Living Donor Liver Transplantation: Outcomes After Maximal Stent TherapyHsieh T, Harrison M, Crowell M, Mekeel K, Aqel B, Carey E, Byrne T, Vargas H, Douglas D, Rakela J, Reddy K, Moss A, Mulligan D. Endoscopic Treatment of Anastomotic Biliary Strictures After Living Donor Liver Transplantation: Outcomes After Maximal Stent Therapy. Clinical Gastroenterology And Hepatology 2011, 9: 184. DOI: 10.1016/j.cgh.2010.11.016.
• Open Sphincteroplasty for Benign Ampullary Stricture After Pancreas TransplantationMekeel KL, Moss AA, Mulligan DC, Reddy KS. Open Sphincteroplasty for Benign Ampullary Stricture After Pancreas Transplantation. American Journal Of Transplantation 2011, 11: 399-402. PMID: 21214856, DOI: 10.1111/j.1600-6143.2010.03369.x.
• Living Donor Kidney Transplantation With Multiple Renal Arteries in the Laparoscopic EraTyson MD, Castle EP, Ko EY, Andrews PE, Heilman RL, Mekeel KL, Moss AA, Mulligan DC, Reddy KS. Living Donor Kidney Transplantation With Multiple Renal Arteries in the Laparoscopic Era. Urology 2010, 77: 1116-1121. PMID: 21145095, DOI: 10.1016/j.urology.2010.07.503.
• Hepatic epithelioid haemangioendothelioma: is transplantation the only treatment option?Grotz TE, Nagorney D, Donohue J, Que F, Kendrick M, Farnell M, Harmsen S, Mulligan D, Nguyen J, Rosen C, Reid-Lombardo K. Hepatic epithelioid haemangioendothelioma: is transplantation the only treatment option? Hepato Pancreato Biliary 2010, 12: 546-553. PMID: 20887322, PMCID: PMC2997660, DOI: 10.1111/j.1477-2574.2010.00213.x.
• Outcomes After Simultaneous Pancreas and Kidney Transplantation and the Discriminative Ability of the C-peptide Measurement Pretransplant Among Type 1 and Type 2 Diabetes MellitusChakkera HA, Bodner JK, Heilman RL, Mulligan DC, Moss AA, Mekeel KL, Mazur MJ, Hamawi K, Ray RM, Beck GL, Reddy KS. Outcomes After Simultaneous Pancreas and Kidney Transplantation and the Discriminative Ability of the C-peptide Measurement Pretransplant Among Type 1 and Type 2 Diabetes Mellitus. Transplantation Proceedings 2010, 42: 2650-2652. PMID: 20832562, PMCID: PMC3060052, DOI: 10.1016/j.transproceed.2010.04.065.
• What Hepatologists Should Know about Liver Transplant SurgeryMekeel K, Mulligan D. What Hepatologists Should Know about Liver Transplant Surgery. 2010, 305-316. DOI: 10.1002/9781444325249.ch30.
• Early Graft Function After Laparoscopically Procured Living Donor Kidney TransplantationTyson M, Castle E, Andrews P, Heilman R, Mekeel K, Moss A, Mulligan D, Reddy K. Early Graft Function After Laparoscopically Procured Living Donor Kidney Transplantation. Journal Of Urology 2010, 184: 1434-1439. PMID: 20727548, DOI: 10.1016/j.juro.2010.06.013.
• Short-Term Cardiac and Noncardiac Mortality Following Liver TransplantationEleid MF, Hurst RT, Vargas HE, Rakela J, Mulligan DC, Appleton CP. Short-Term Cardiac and Noncardiac Mortality Following Liver Transplantation. Journal Of Transplantation 2010, 2010: 910165. PMID: 20814597, PMCID: PMC2931376, DOI: 10.1155/2010/910165.
• ADVERSE IMPACT OF MILD HYPERTENSION POST TRANSPLANT ON 1 YEAR CHRONIC INTERSTIAL FIBROSIS AND TUBULAR ATROPY SCORES IN KIDNEY ALLOGRAFT BIOPSY AMONG A COHORT ON RAPID STEROID WITHDRAWL PROTOCOL.Chakkera H, Devarapalli Y, Mulligan D, Mazur M, Hamawi K, Reddy K, Moss A, Mekeel K, Heilman R. ADVERSE IMPACT OF MILD HYPERTENSION POST TRANSPLANT ON 1 YEAR CHRONIC INTERSTIAL FIBROSIS AND TUBULAR ATROPY SCORES IN KIDNEY ALLOGRAFT BIOPSY AMONG A COHORT ON RAPID STEROID WITHDRAWL PROTOCOL. Transplantation 2010, 90: 387. DOI: 10.1097/00007890-201007272-00715.
• SUBCLINICAL ACUTE REJECTION IS ASSOCIATED WITH INFERIOR GRAFT SURVIVAL IN KIDNEY TRANSPLANT RECIPIENTS ON RAPID STEROID WITHDRAWALHeilman R, Davarapalli Y, Chakkera H, Mekeel K, Moss A, Williams J, Hamawi K, Mazur M, Mulligan D, Reddy K. SUBCLINICAL ACUTE REJECTION IS ASSOCIATED WITH INFERIOR GRAFT SURVIVAL IN KIDNEY TRANSPLANT RECIPIENTS ON RAPID STEROID WITHDRAWAL. Transplantation 2010, 90: 176. DOI: 10.1097/00007890-201007272-00341.
• LIVER TRANSPLANTATION IN THE OBESE CLASS II AND III RECIPIENTMoss A, Douglas D, Reddy K, Mekeel K, Aqel B, Carey E, Byrne T, Vargas H, Rakela J, Mulligan D. LIVER TRANSPLANTATION IN THE OBESE CLASS II AND III RECIPIENT. Transplantation 2010, 90: 845. DOI: 10.1097/00007890-201007272-01650.
• ASSOCIATION OF A COMPOSITE SET OF PREDICTORS PRE TRANSPLANTATION AND NEW ONSET DIABETES MELLITUS AFTER KIDNEY TRANSPLANTATIONChakkera H, Devarapalli Y, Reddy K, Mulligan D, Mazur M, Hamawi K, Moss A, Mekeel K, Swanson C, Heilman R. ASSOCIATION OF A COMPOSITE SET OF PREDICTORS PRE TRANSPLANTATION AND NEW ONSET DIABETES MELLITUS AFTER KIDNEY TRANSPLANTATION. Transplantation 2010, 90: 928. DOI: 10.1097/00007890-201007272-01820.
• Alemtuzumab with Rapid Steroid Taper in Simultaneous Kidney and Pancreas Transplantation: Comparison to Induction with Antithymocyte GlobulinReddy K, Devarapalli Y, Mazur M, Hamawi K, Chakkera H, Moss A, Mekeel K, Post D, Heilman R, Mulligan D. Alemtuzumab with Rapid Steroid Taper in Simultaneous Kidney and Pancreas Transplantation: Comparison to Induction with Antithymocyte Globulin. Transplantation Proceedings 2010, 42: 2006-2008. PMID: 20692393, DOI: 10.1016/j.transproceed.2010.05.090.
• THE RISK OF HEPATIC ARTERIAL COMPLICATIONS ASSOCIATED WITH TRANS-ARTERIAL CHEMOEMBOLIZATION PRIOR TO LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA.Mekeel K, Moss A, Reddy K, Byrne T, Douglas D, Naidu S, Huettl E, Mulligan D. THE RISK OF HEPATIC ARTERIAL COMPLICATIONS ASSOCIATED WITH TRANS-ARTERIAL CHEMOEMBOLIZATION PRIOR TO LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA. Transplantation 2010, 90: 781. DOI: 10.1097/00007890-201007272-01516.
• Relationship between Inpatient Hyperglycemia and Insulin Treatment after Kidney Transplantation and Future New Onset Diabetes MellitusChakkera HA, Knowler WC, Devarapalli Y, Weil EJ, Heilman RL, Dueck A, Mulligan DC, Reddy KS, Moss AA, Mekeel KL, Mazur MJ, Hamawi K, Castro JC, Cook CB. Relationship between Inpatient Hyperglycemia and Insulin Treatment after Kidney Transplantation and Future New Onset Diabetes Mellitus. Clinical Journal Of The American Society Of Nephrology 2010, 5: 1669-1675. PMID: 20558559, PMCID: PMC2974410, DOI: 10.2215/cjn.09481209.
• 2168 INITIAL GRAFT FUNCTION AFTER LAPAROSCOPICALLY PROCURED LIVING DONOR KIDNEY TRANSPLANTATIONTyson M, Castle E, Andrews P, Heilman R, Mekeel K, Moss A, Mulligan D, Reddy K. 2168 INITIAL GRAFT FUNCTION AFTER LAPAROSCOPICALLY PROCURED LIVING DONOR KIDNEY TRANSPLANTATION. Journal Of Urology 2010, 183: e843-e844. DOI: 10.1016/j.juro.2010.02.2271.
• Successful Transplantation of a Split Crossed Fused Ectopic Kidney into a Patient with End-Stage Renal DiseaseMekeel KL, Daley SM, Andrews PE, Moss AA, Heilman RL, Mazur MJ, Chakkera HA, Hamawi K, Mulligan DC, Reddy K. Successful Transplantation of a Split Crossed Fused Ectopic Kidney into a Patient with End-Stage Renal Disease. Journal Of Transplantation 2010, 2010: 383972. PMID: 20368777, PMCID: PMC2846343, DOI: 10.1155/2010/383972.
• Impact of Subclinical Inflammation on the Development of Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant RecipientsHeilman RL, Devarapalli Y, Chakkera HA, Mekeel KL, Moss AA, Mulligan DC, Mazur MJ, Hamawi K, Williams JW, Reddy KS. Impact of Subclinical Inflammation on the Development of Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients. American Journal Of Transplantation 2010, 10: 563-570. PMID: 20121731, DOI: 10.1111/j.1600-6143.2009.02966.x.
• Nucleic Acid Testing (NAT) of Organ Donors: Is the ‘Best’ Test the Right Test? A Consensus Conference ReportHumar A, Morris M, Blumberg E, Freeman R, Preiksaitis J, Kiberd B, Schweitzer E, Ganz S, Caliendo A, Orlowski J, Wilson B, Kotton C, Michaels M, Kleinman S, Geier S, Murphy B, Green M, Levi M, Knoll G, Segev D, Brubaker S, Hasz R, Lebovitz D, Mulligan D, O’Connor K, Pruett T, Mozes M, Lee I, Delmonico F, Fischer S. Nucleic Acid Testing (NAT) of Organ Donors: Is the ‘Best’ Test the Right Test? A Consensus Conference Report. American Journal Of Transplantation 2010, 10: 889-899. PMID: 20121734, DOI: 10.1111/j.1600-6143.2009.02992.x.
• Pilot Study: Association of Traditional and Genetic Risk Factors and New-Onset Diabetes Mellitus Following Kidney TransplantationChakkera HA, Hanson RL, Raza SM, DiStefano JK, Millis MP, Heilman RL, Mulligan DC, Reddy KS, Mazur MJ, Hamawi K, Moss AA, Mekeel KL, Cerhan JR. Pilot Study: Association of Traditional and Genetic Risk Factors and New-Onset Diabetes Mellitus Following Kidney Transplantation. Transplantation Proceedings 2009, 41: 4172-4177. PMID: 20005362, PMCID: PMC3478878, DOI: 10.1016/j.transproceed.2009.08.063.
• Natural history of post–liver transplantation hepatitis C: A review of factors that may influence its courseGallegos‐Orozco J, Yosephy A, Noble B, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan D, Moss A, de Petris G, Williams JW, Rakela J, Vargas HE. Natural history of post–liver transplantation hepatitis C: A review of factors that may influence its course. Liver Transplantation 2009, 15: 1872-1881. PMID: 19938138, DOI: 10.1002/lt.21954.
• Monoclonal Gammopathy of Undetermined Significance (MGUS) Does Not Affect Outcomes in Patients Undergoing Solid Transplants.Jimenez-Zepeda V, Heilman R, Mulligan D, Stewart A. Monoclonal Gammopathy of Undetermined Significance (MGUS) Does Not Affect Outcomes in Patients Undergoing Solid Transplants. Blood 2009, 114: 2834. DOI: 10.1182/blood.v114.22.2834.2834.
• Living donor liver transplantation and donor graft size: How small can we go to reduce risk to the donor and what is the cost to the recipient?Mulligan D. Living donor liver transplantation and donor graft size: How small can we go to reduce risk to the donor and what is the cost to the recipient? Liver Transplantation 2009, 15: 1392-1394. PMID: 19877257, DOI: 10.1002/lt.21922.
• Simultaneous Heart and Kidney Transplantation After Bridging With The CardioWest Total Artificial HeartJaroszewski DE, Pierce CC, Staley LL, Wong R, Scott RR, Steidley EE, Gopalan RS, DeValeria P, Lanza L, Mulligan D, Arabia FA. Simultaneous Heart and Kidney Transplantation After Bridging With The CardioWest Total Artificial Heart. The Annals Of Thoracic Surgery 2009, 88: 1324-1326. PMID: 19766830, DOI: 10.1016/j.athoracsur.2009.02.056.
• ASTS Recommended Practice Guidelines for Controlled Donation after Cardiac Death Organ Procurement and TransplantationReich DJ, Mulligan DC, Abt PL, Pruett TL, Abecassis MM, D’Alessandro A, Pomfret EA, Freeman RB, Markmann JF, Hanto DW, Matas AJ, Roberts JP, Merion RM, Klintmalm GB, Committee T. ASTS Recommended Practice Guidelines for Controlled Donation after Cardiac Death Organ Procurement and Transplantation. American Journal Of Transplantation 2009, 9: 2004-2011. PMID: 19624569, DOI: 10.1111/j.1600-6143.2009.02739.x.
• Deceased Donor Kidney Transplantation from Donors with Acute Renal Failure due to RhabdomyolysisMekeel KL, Moss AA, Mulligan DC, Chakkera HA, Hamawi K, Mazur MJ, Heilman RL, Reddy KS. Deceased Donor Kidney Transplantation from Donors with Acute Renal Failure due to Rhabdomyolysis. American Journal Of Transplantation 2009, 9: 1666-1670. PMID: 19459799, DOI: 10.1111/j.1600-6143.2009.02663.x.
• 498 NATURAL HISTORY OF HEPATITIS C AFTER LIVER TRANSPLANTATION: A SINGLE CENTER EXPERIENCEYosephy A, Gallegos-Orozco J, Byrne T, Noble B, Aqel B, Carey E, Douglas D, Mulligan D, Rakela J, Vargas H. 498 NATURAL HISTORY OF HEPATITIS C AFTER LIVER TRANSPLANTATION: A SINGLE CENTER EXPERIENCE. Journal Of Hepatology 2009, 50: s186. DOI: 10.1016/s0168-8278(09)60500-6.
• Hyperglycemia during the Immediate Period after Kidney TransplantationChakkera HA, Weil EJ, Castro J, Heilman RL, Reddy KS, Mazur MJ, Hamawi K, Mulligan DC, Moss AA, Mekeel KL, Cosio FG, Cook CB. Hyperglycemia during the Immediate Period after Kidney Transplantation. Clinical Journal Of The American Society Of Nephrology 2009, 4: 853-859. PMID: 19339426, PMCID: PMC2666437, DOI: 10.2215/cjn.05471008.
• Sclerosing peritonitis and mortality after liver transplantationMekeel K, Moss A, Reddy KS, Douglas D, Mulligan D. Sclerosing peritonitis and mortality after liver transplantation. Liver Transplantation 2009, 15: 435-439. PMID: 19326414, DOI: 10.1002/lt.21702.
• Hemobilia and pancreatitis after liver transplant biopsyLi F, Mekeel KL, Eleid M, Harrison ME, Reddy KS, Moss AA, Mulligan DC. Hemobilia and pancreatitis after liver transplant biopsy. Liver Transplantation 2009, 15: 350-351. PMID: 19243004, DOI: 10.1002/lt.21619.
• Plasmapheresis therapy for rare but potentially fatal reaction to rituximabHastings D, Patel B, Torloni AS, Mookadam F, Betcher J, Moss A, Heilman R, Mazur M, Hamawi K, Mulligan D, Reddy K, Mekeel K, Chakkera H. Plasmapheresis therapy for rare but potentially fatal reaction to rituximab. Journal Of Clinical Apheresis 2009, 24: 28-31. PMID: 19156754, DOI: 10.1002/jca.20187.
• Outcomes of Simultaneous Kidney–Pancreas Transplantation With Positive Cross-MatchHeilman R, Chakkera H, Mazur M, Petrides S, Moss A, Mekeel K, Mulligan D, Reddy K. Outcomes of Simultaneous Kidney–Pancreas Transplantation With Positive Cross-Match. Transplantation Proceedings 2009, 41: 303-306. PMID: 19249540, DOI: 10.1016/j.transproceed.2008.08.154.
• Use of bortezomib for treatment of antibody medicated rejection in kidney transplant recipients--case report.Hamawi K, Heilman RL, Mazur MJ, Chakkera HA, Mulligan DC, Moss AA, Mekeel KL, Reddy KS. Use of bortezomib for treatment of antibody medicated rejection in kidney transplant recipients--case report. Clinical Transplants 2009, 407-14. PMID: 20524306.
• Laparoscopic Fenestration of Giant Hepatic CystsMekeel KL, Moss AA, Reddy KS, Mulligan DC, Harold KL. Laparoscopic Fenestration of Giant Hepatic Cysts. Surgical Laparoscopy Endoscopy & Percutaneous Techniques 2008, 18: 511-513. PMID: 18936679, DOI: 10.1097/sle.0b013e31817739e7.
• Utility of the Endovascular Stapler for Right-Sided Laparoscopic Donor Nephrectomy: A 7-Year Experience at Mayo ClinicKo EY, Castle EP, Desai PJ, Moss AA, Reddy KS, Mekeel KL, Mulligan DC, Andrews PE. Utility of the Endovascular Stapler for Right-Sided Laparoscopic Donor Nephrectomy: A 7-Year Experience at Mayo Clinic. Journal Of The American College Of Surgeons 2008, 207: 896-903. PMID: 19183537, DOI: 10.1016/j.jamcollsurg.2008.07.013.
• HEPATIC ARTERY THROMBOSIS AFTER ADULT LIVING DONOR LIVER TRANSPLANTATION: RISK FACTORS AND MANAGEMENT FOR SUCCESSFUL OUTCOMESMulligan D, Moss A, Reddy S, Mekeel K, Byrne T, Carey E, Harrison M, Vargas H, Douglas D, Rakela J. HEPATIC ARTERY THROMBOSIS AFTER ADULT LIVING DONOR LIVER TRANSPLANTATION: RISK FACTORS AND MANAGEMENT FOR SUCCESSFUL OUTCOMES. Transplantation 2008, 86: 47. DOI: 10.1097/01.tp.0000332676.37855.56.
• SIMULTANEOUS KIDNEY PANCREAS TRANSPLANTATION USING RAPID STEROID TAPER WITH PROTOCOL BIOPSIES: COMPARISON OF R-ATG VERSUS ALEMTUZUMABHeilman R, Reddy K, Moss A, Mazur M, Mekeel K, Chakkera H, Post D, Mulligan D. SIMULTANEOUS KIDNEY PANCREAS TRANSPLANTATION USING RAPID STEROID TAPER WITH PROTOCOL BIOPSIES: COMPARISON OF R-ATG VERSUS ALEMTUZUMAB. Transplantation 2008, 86: 50. DOI: 10.1097/01.tp.0000332690.44585.05.
• RISK FACTORS FOR ANTIBODY MEDIATED REJECTION (AMR) IN KIDNEY TRANSPLANT (KTX) RECIPIENTS WITH POSITIVE CDC B-CELL / FLOW CYTOMETRY CROSSMATCH (CXM) TREATED WITH LOE DOSE INTRAVENOUS IMMUNOGLOBULIN (IVIG) AND RATG THERAPYMoss A, Heilman R, Chakkera H, Mazur M, Petrides S, Wosniak E, Mekeel K, Mulligan D, Reddy K. RISK FACTORS FOR ANTIBODY MEDIATED REJECTION (AMR) IN KIDNEY TRANSPLANT (KTX) RECIPIENTS WITH POSITIVE CDC B-CELL / FLOW CYTOMETRY CROSSMATCH (CXM) TREATED WITH LOE DOSE INTRAVENOUS IMMUNOGLOBULIN (IVIG) AND RATG THERAPY. Transplantation 2008, 86: 591-592. DOI: 10.1097/01.tp.0000330970.94094.7a.
• SIMULTANEOUS KIDNEY PANCREAS TRANSPLANTATION IN PATIENTS WITH POSITIVE CDC B-CELL AND/OR FLOW CYTOMETRY CROSSMATCHHeilman R, Moss A, Mazur M, Chakkera H, Mekeel K, Mulligan D, Reddy K. SIMULTANEOUS KIDNEY PANCREAS TRANSPLANTATION IN PATIENTS WITH POSITIVE CDC B-CELL AND/OR FLOW CYTOMETRY CROSSMATCH. Transplantation 2008, 86: 152. DOI: 10.1097/01.tp.0000332265.44284.23.
• A CHANGE IN BILIARY ANASTOMOTIC TECHNIQUE LEADS TO A SIGNIFICANT IMPACT ON COMPLICATIONS FOLLOWING ADULT LIVING DONOR LIVER TRANSPLANTATION (LDLT)Moss A, Mekeel K, Reddy K, Harrison M, Douglas D, Vargas H, Carey E, Byrne T, Mulligan D. A CHANGE IN BILIARY ANASTOMOTIC TECHNIQUE LEADS TO A SIGNIFICANT IMPACT ON COMPLICATIONS FOLLOWING ADULT LIVING DONOR LIVER TRANSPLANTATION (LDLT). Transplantation 2008, 86: 442. DOI: 10.1097/01.tp.0000331447.70202.92.
• Living donor liver transplantation in polycystic liver diseaseMekeel KL, Moss AA, Reddy KS, Douglas DD, Vargas HE, Carey EJ, Byrne TJ, Harrison ME, Rakela J, Mulligan DC. Living donor liver transplantation in polycystic liver disease. Liver Transplantation 2008, 14: 680-683. PMID: 18433036, DOI: 10.1002/lt.21423.
• Clinical factors associated with graft fibrosis in kidney‐transplant recipients on steroid‐avoidance immunosuppressionHeilman RL, Chakkera HA, Reddy KS, Colby TV, Moss AA, Williams JW, Mazur MJ, Petrides S, Mulligan DC. Clinical factors associated with graft fibrosis in kidney‐transplant recipients on steroid‐avoidance immunosuppression. Clinical Transplantation 2007, 22: 309-315. PMID: 18482051, DOI: 10.1111/j.1399-0012.2007.00786.x.
• Laparoscopic incisional hernia repair after liver transplantationMekeel K, Mulligan D, Reddy KS, Moss A, Harold K. Laparoscopic incisional hernia repair after liver transplantation. Liver Transplantation 2007, 13: 1576-1581. PMID: 17969189, DOI: 10.1002/lt.21290.
• Hemosuccus Pancreaticus in the Era of Capsule Endoscopy and Double Balloon Enteroscopy Complicated by Multifocal Mycobacterium chelonae/abscessus InfectionPasha SF, Blair JE, Garvey PB, Gray RJ, Mulligan DC, Collins JM, Heigh RI. Hemosuccus Pancreaticus in the Era of Capsule Endoscopy and Double Balloon Enteroscopy Complicated by Multifocal Mycobacterium chelonae/abscessus Infection. Case Reports In Gastroenterology 2007, 1: 38-47. PMID: 21487470, PMCID: PMC3073786, DOI: 10.1159/000104977.
• Endoscopic treatment of anastomotic biliary strictures after deceased donor liver transplantation: outcomes after maximal stent therapyPasha SF, Harrison ME, Das A, Nguyen CC, Vargas HE, Balan V, Byrne TJ, Douglas DD, Mulligan DC. Endoscopic treatment of anastomotic biliary strictures after deceased donor liver transplantation: outcomes after maximal stent therapy. Gastrointestinal Endoscopy 2007, 66: 44-51. PMID: 17591473, DOI: 10.1016/j.gie.2007.02.017.
• Diffuse Parenchymal Urine Leak After Kidney Transplantation Following Degloving Injury During Donor NephrectomyMekeel KL, Mazur MJ, Reddy KS, Mulligan DC, Heilman RL, Chakkera HA, Andrews PE, Moss AA. Diffuse Parenchymal Urine Leak After Kidney Transplantation Following Degloving Injury During Donor Nephrectomy. American Journal Of Transplantation 2007, 7: 2039-2041. PMID: 17578504, DOI: 10.1111/j.1600-6143.2007.01870.x.
• Coccidioidomycosis masked by symptoms of end‐stage liver disease in transplant candidatesSachdev MS, Blair JE, Mulligan DC, Kusne S. Coccidioidomycosis masked by symptoms of end‐stage liver disease in transplant candidates. Transplant Infectious Disease 2007, 9: 153-155. PMID: 17462003, DOI: 10.1111/j.1399-3062.2007.00215.x.
• Kluyvera co‐infection in two solid organ transplant recipients: an emerging pathogen or a colonizer bystander?Cheruvattath R, Balan V, Stewart R, Heilman RL, Mulligan DC, Kusne S. Kluyvera co‐infection in two solid organ transplant recipients: an emerging pathogen or a colonizer bystander? Transplant Infectious Disease 2007, 9: 83-86. PMID: 17313481, DOI: 10.1111/j.1399-3062.2006.00198.x.
• Coccidioidomycosis in healthy persons evaluated for liver or kidney donationBlair JE, Mulligan DC. Coccidioidomycosis in healthy persons evaluated for liver or kidney donation. Transplant Infectious Disease 2007, 9: 78-82. PMID: 17313480, DOI: 10.1111/j.1399-3062.2006.00179.x.
• Model for end‐stage liver disease (MELD) exception for hepatopulmonary syndromeFallon MB, Mulligan DC, Gish RG, Krowka MJ. Model for end‐stage liver disease (MELD) exception for hepatopulmonary syndrome. Liver Transplantation 2006, 12: s105-s107. PMID: 17123282, DOI: 10.1002/lt.20971.
• Model for end‐stage liver disease (MELD) exception for portopulmonary hypertensionKrowka MJ, Fallon MB, Mulligan DC, Gish RG. Model for end‐stage liver disease (MELD) exception for portopulmonary hypertension. Liver Transplantation 2006, 12: s114-s116. PMID: 17123283, DOI: 10.1002/lt.20975.
• A worldwide database for living donor liver transplantation is long overdueMulligan DC. A worldwide database for living donor liver transplantation is long overdue. Liver Transplantation 2006, 12: 1443-1444. PMID: 17004258, DOI: 10.1002/lt.20925.
• CHANGES IN SF-36 QUALITY OF LIFE (QOL) SCALES AFTER RIGHT HEPATECTOMY FOR ADULT LIVING DONOR LIVER TRANSPLANTATION (ALDLT).Cheruvattath R, Douglas D, Russell L, Byrne T, Balan V, Vargas H, Rakela J, Chopra K, Carey E, Harrison M, Reddy K, Moss A, Mulligan D. CHANGES IN SF-36 QUALITY OF LIFE (QOL) SCALES AFTER RIGHT HEPATECTOMY FOR ADULT LIVING DONOR LIVER TRANSPLANTATION (ALDLT). Transplantation 2006, 82: 466. DOI: 10.1097/00007890-200607152-01200.
• DONOR PERCEPTION AFTER RIGHT HEPATECTOMY FOR LDLT: INSIGHTS FOR IMPROVING FOLLOW-UP CARE.Russell L, Cheruvattath R, Douglas D, Moss A, Mulligan D. DONOR PERCEPTION AFTER RIGHT HEPATECTOMY FOR LDLT: INSIGHTS FOR IMPROVING FOLLOW-UP CARE. Transplantation 2006, 82: 709. DOI: 10.1097/00007890-200607152-01940.
• METICULOUS TRIAGE IN DONOR SCREENING HELPS IMPROVE EFFICIENCY IN LIVING DONOR LIVER TRANSPLANTATION AND OPTIMIZES OUTCOMES.Cheruvattath R, Douglas D, Moss A, Russell L, Mulligan D. METICULOUS TRIAGE IN DONOR SCREENING HELPS IMPROVE EFFICIENCY IN LIVING DONOR LIVER TRANSPLANTATION AND OPTIMIZES OUTCOMES. Transplantation 2006, 82: 845. DOI: 10.1097/00007890-200607152-02363.
• CLINICAL VARIABLES ASSOCIATED WITH GRAFT FIBROSIS (GF) ON 12 MONTH PROTOCOL BIOPSY IN KIDNEY TRANSPLANT RECIPIENTS ON STEROID AVOIDANCE IMMUNOSUPPRESSION (SA).Heilman R, Reddy K, Chakkera H, Mazur M, Moss A, Williams J, Colby T, Petrides S, Mulligan D. CLINICAL VARIABLES ASSOCIATED WITH GRAFT FIBROSIS (GF) ON 12 MONTH PROTOCOL BIOPSY IN KIDNEY TRANSPLANT RECIPIENTS ON STEROID AVOIDANCE IMMUNOSUPPRESSION (SA). Transplantation 2006, 82: 461-462. DOI: 10.1097/00007890-200607152-01187.
• DONORS CAN HAVE EXCELLENT OUTCOMES FOLLOWING RIGHT HEPATECTOMY FOR LIVING DONOR LIVER TRANSPLANTATION.Mulligan D, Moss A, Reddy K, Cheruvattath R, Russell L, Balan V, Byrne T, Chopra K, Harrison M, Vargas H, Rakela J, Douglas D. DONORS CAN HAVE EXCELLENT OUTCOMES FOLLOWING RIGHT HEPATECTOMY FOR LIVING DONOR LIVER TRANSPLANTATION. Transplantation 2006, 82: 846. DOI: 10.1097/00007890-200607152-02366.
• POLYOMAVIRUS SHEDDING IN SOLID ORGAN TRANSPLANT RECIPIENTS RECEIVING CALCINEURIN INHIBITORS AND MYCOPHENOLIC ACID.Kusne S, Vilchez R, Zanwar P, Mazur M, Heilman R, Mulligan D, Butel J. POLYOMAVIRUS SHEDDING IN SOLID ORGAN TRANSPLANT RECIPIENTS RECEIVING CALCINEURIN INHIBITORS AND MYCOPHENOLIC ACID. Transplantation 2006, 82: 685. DOI: 10.1097/00007890-200607152-01868.
• THE INFLUENCE OF DONOR-SPECIFIC ANTIBODIES IN KIDNEY TRANSPLANT RECIPIENTS WITH POSITIVE CDC B-CELL/FLOW CYTOMETRY CROSSMATCH TREATED WITH LOW DOSE INTRAVENOUS IMMUNOGLOBULIN AND ANTI-THYMOCYTE GLOBULIN INDUCTION THERAPY.Moss A, Heilman R, Mazur M, Chakkera H, Wozniak E, Post D, Mulligan D, Reddy K. THE INFLUENCE OF DONOR-SPECIFIC ANTIBODIES IN KIDNEY TRANSPLANT RECIPIENTS WITH POSITIVE CDC B-CELL/FLOW CYTOMETRY CROSSMATCH TREATED WITH LOW DOSE INTRAVENOUS IMMUNOGLOBULIN AND ANTI-THYMOCYTE GLOBULIN INDUCTION THERAPY. Transplantation 2006, 82: 292. DOI: 10.1097/00007890-200607152-00679.
• RESOURCE UTILIZATION IN KIDNEY TRANSPLANT RECIPIENTS WITH POSITIVE CDC B CELL, FLOW B AND/OR T CELL CROSS MATCH TREATED WITH LOW DOSE IVIG AND THYMOGLOBULIN® INDUCTION THERAPY.Post D, Moss A, Mulligan D, Heilman R, Mazur M, Chakkera H, Reddy K. RESOURCE UTILIZATION IN KIDNEY TRANSPLANT RECIPIENTS WITH POSITIVE CDC B CELL, FLOW B AND/OR T CELL CROSS MATCH TREATED WITH LOW DOSE IVIG AND THYMOGLOBULIN® INDUCTION THERAPY. Transplantation 2006, 82: 668. DOI: 10.1097/00007890-200607152-01815.
• Reduced Priority MELD Score for Hepatocellular Carcinoma Does Not Adversely Impact Candidate Survival Awaiting Liver TransplantationSharma P, Harper AM, Hernandez JL, Heffron T, Mulligan DC, Wiesner RH, Balan V. Reduced Priority MELD Score for Hepatocellular Carcinoma Does Not Adversely Impact Candidate Survival Awaiting Liver Transplantation. American Journal Of Transplantation 2006, 6: 1957-1962. PMID: 16771808, DOI: 10.1111/j.1600-6143.2006.01411.x.
• Acute Rejection Risk in Kidney Transplant Recipients on Steroid-Avoidance Immunosuppression Receiving Induction With Either Antithymocyte Globulin or BasiliximabHeilman RL, Reddy KS, Mazur MJ, Moss AA, Post DJ, Petrides S, Mulligan DC. Acute Rejection Risk in Kidney Transplant Recipients on Steroid-Avoidance Immunosuppression Receiving Induction With Either Antithymocyte Globulin or Basiliximab. Transplantation Proceedings 2006, 38: 1307-1313. PMID: 16797289, DOI: 10.1016/j.transproceed.2006.02.116.
• Liver Transplantation in the MELD Era: A Single-Center ExperienceSachdev M, Hernandez JL, Sharma P, Douglas DD, Byrne T, Harrison ME, Mulligan D, Moss A, Reddy K, Vargas HE, Rakela J, Balan V. Liver Transplantation in the MELD Era: A Single-Center Experience. Digestive Diseases And Sciences 2006, 51: 1070-1078. PMID: 16865573, DOI: 10.1007/s10620-006-8011-1.
• Living donor liver transplantation for hepatitis C‐related cirrhosis: No difference in histological recurrence when compared to deceased donor liver transplantation recipientsGuo L, Orrego M, Rodriguez‐Luna H, Balan V, Byrne T, Chopra K, Douglas DD, Harrison E, Moss A, Reddy KS, Williams JW, Rakela J, Mulligan D, Vargas HE. Living donor liver transplantation for hepatitis C‐related cirrhosis: No difference in histological recurrence when compared to deceased donor liver transplantation recipients. Liver Transplantation 2006, 12: 560-565. PMID: 16555313, DOI: 10.1002/lt.20660.
• Immunosuppression in liver transplantationPost DJ, Douglas DD, Mulligan DC. Immunosuppression in liver transplantation. Liver Transplantation 2005, 11: 1307-1314. PMID: 16237688, DOI: 10.1002/lt.20614.
• Regional Variations in Peer Reviewed Liver Allocation Under the MELD SystemRodriguez‐Luna H, Vargas HE, Moss A, Reddy KS, Freeman RB, Mulligan D. Regional Variations in Peer Reviewed Liver Allocation Under the MELD System. American Journal Of Transplantation 2005, 5: 2244-2247. PMID: 16095504, DOI: 10.1111/j.1600-6143.2005.01008.x.
• A Comparison of Transfusion Requirements Between Living Donation and Cadaveric Donation Liver Transplantation: Relationship to Model of End-Stage Liver Disease Score and Baseline Coagulation StatusFrasco PE, Poterack KA, Hentz JG, Mulligan DC. A Comparison of Transfusion Requirements Between Living Donation and Cadaveric Donation Liver Transplantation: Relationship to Model of End-Stage Liver Disease Score and Baseline Coagulation Status. Anesthesia & Analgesia 2005, 101: 30-37. PMID: 15976201, DOI: 10.1213/01.ane.0000155288.57914.0d.
• Hepatic B‐cell non‐Hodgkin's lymphoma of MALT type in the liver explant of a patient with chronic hepatitis C infectionOrrego M, Guo L, Reeder C, De Petris G, Balan V, Douglas DD, Byrne T, Harrison E, Mulligan D, Rodriguez‐Luna H, Moss A, Reddy K, Rakela J, Vargas HE. Hepatic B‐cell non‐Hodgkin's lymphoma of MALT type in the liver explant of a patient with chronic hepatitis C infection. Liver Transplantation 2005, 11: 796-799. PMID: 15973702, DOI: 10.1002/lt.20384.
• Steroid Avoidance Immunosuppression in Low-Risk Kidney Transplant RecipientsHeilman R, Mazur M, Reddy K, Moss A, Post D, Mulligan D. Steroid Avoidance Immunosuppression in Low-Risk Kidney Transplant Recipients. Transplantation Proceedings 2005, 37: 1785-1788. PMID: 15919466, DOI: 10.1016/j.transproceed.2005.02.106.
• Hospital cost of right hepatectomy: Adult-to-adult living donor vs. benign and malignant indicationsDouglas D, Moss A, Reddy K, Durocher D, Rakela J, Vargas H, Balan V, Byrne T, Harrison M, Mulligan D. Hospital cost of right hepatectomy: Adult-to-adult living donor vs. benign and malignant indications. Journal Of Gastrointestinal Surgery 2005, 9: 546. DOI: 10.1016/j.gassur.2005.01.067.
• Liver transplant in a patient with a ventriculoperitoneal shuntFaybush E, Mulligan DC, Birch BD, Sirven JI, Balan V. Liver transplant in a patient with a ventriculoperitoneal shunt. Liver Transplantation 2005, 11: 467-468. PMID: 15776410, DOI: 10.1002/lt.20371.
• Liver transplantation for hepatocellular cancer: The impact of the MELD allocation policyWiesner RH, Freeman RB, Mulligan DC. Liver transplantation for hepatocellular cancer: The impact of the MELD allocation policy. Gastroenterology 2004, 127: s261-s267. PMID: 15508092, DOI: 10.1053/j.gastro.2004.09.040.
• LIVER TRANSPLANT DURING ACTIVE COCCIDIOIDES INFECTIONSachdev M, Blair J, Petre S, Mulligan D, Kusne S. LIVER TRANSPLANT DURING ACTIVE COCCIDIOIDES INFECTION. The American Journal Of Gastroenterology 2004, 99: s96. DOI: 10.14309/00000434-200410001-00294.
• DIAGNOSIS AND ENDOSCOPIC TREATMENT OF ANASTOMOTIC BILIARY STRICTURES AFTER DECEASED DONOR LIVER TRANSPLANTHarrison M, Nguyen C, Byrne T, Vargas H, Balan V, Douglas D, Moss A, Reddy K, Mulligan D, Rakela J. DIAGNOSIS AND ENDOSCOPIC TREATMENT OF ANASTOMOTIC BILIARY STRICTURES AFTER DECEASED DONOR LIVER TRANSPLANT. The American Journal Of Gastroenterology 2004, 99: s72-s73. DOI: 10.14309/00000434-200410001-00220.
• Hepatitis C Virus Infection with Hepatocellular Carcinoma: Not A Controversial Indication for Liver TransplantationRodriguez-Luna H, Balan V, Sharma P, Byrne T, Mulligan D, Rakela J, Vargas HE. Hepatitis C Virus Infection with Hepatocellular Carcinoma: Not A Controversial Indication for Liver Transplantation. Transplantation 2004, 78: 580-583. PMID: 15446318, DOI: 10.1097/01.tp.0000129797.30999.69.
• Significance of Proximal Biliary Dilatation in Patients with Anastomotic Strictures After Liver TransplantationSt. Peter S, Rodriquez-Davalos MI, Rodriguez-Luna HM, Harrison EM, Moss AA, Mulligan DC. Significance of Proximal Biliary Dilatation in Patients with Anastomotic Strictures After Liver Transplantation. Digestive Diseases And Sciences 2004, 49: 1207-1211. PMID: 15387348, DOI: 10.1023/b:ddas.0000037814.96308.7a.
• New preservation solutions for use in liver transplantationMulligan D, Reddy K, Moss A. New preservation solutions for use in liver transplantation. Current Opinion In Organ Transplantation 2004, 9: 159-162. DOI: 10.1097/01.mot.0000127629.78517.06.
• Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation.Arenas JI, Gallegos-Orozco JF, Laskus T, Wilkinson J, Khatib A, Fasola C, Adair D, Radkowski M, Kibler KV, Nowicki M, Douglas D, Williams J, Netto G, Mulligan D, Klintmalm G, Rakela J, Vargas HE. Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation. The Journal Of Infectious Diseases 2004, 189: 2037-46. PMID: 15143471, DOI: 10.1086/386338.
• Hepatopulmonary syndrome after living donor liver transplantation and deceased donor liver transplantation: A single‐center experienceCarey EJ, Douglas DD, Balan V, Vargas HE, Byrne TJ, Moss AA, Mulligan DC. Hepatopulmonary syndrome after living donor liver transplantation and deceased donor liver transplantation: A single‐center experience. Liver Transplantation 2004, 10: 529-533. PMID: 15048796, DOI: 10.1002/lt.20127.
• Hepatitis C Virus Recurrence in Living Donor Liver Transplant RecipientsRodriguez-Luna H, Vargas HE, Sharma P, Ortiz J, De Petris G, Balan V, Byrne T, Moss A, Mulligan D, Rakela J, Douglas DD. Hepatitis C Virus Recurrence in Living Donor Liver Transplant Recipients. Digestive Diseases And Sciences 2004, 49: 38-41. PMID: 14992432, DOI: 10.1023/b:ddas.0000011599.78222.9e.
• Liver transplantation for hepatocellular carcinoma: The MELD impactSharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez‐Luna H, Byrne T, Vargas HE, Mulligan D, Rakela J, Wiesner RH. Liver transplantation for hepatocellular carcinoma: The MELD impact. Liver Transplantation 2004, 10: 36-41. PMID: 14755775, DOI: 10.1002/lt.20012.
• Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon &agr;2b and ribavirin: an open-label series1Rodriguez-Luna H, Khatib A, Sharma P, De Petris G, Williams JW, Ortiz J, Hansen K, Mulligan D, Moss A, Douglas DD, Balan V, Rakela J, Vargas HE. Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon &agr;2b and ribavirin: an open-label series1. Transplantation 2004, 77: 190-194. PMID: 14742979, DOI: 10.1097/01.tp.0000100481.14514.bb.
• Outcome of liver transplantation for familial amyloidotic polyneuropathySharma P, Perri RE, Sirven JE, Zeldenrust SR, Brandhagen DJ, Rosen CB, Douglas DD, Mulligan DC, Rakela J, Wiesner RH, Balan V. Outcome of liver transplantation for familial amyloidotic polyneuropathy. Liver Transplantation 2003, 9: 1273-1280. PMID: 14625827, DOI: 10.1016/j.lts.2003.09.016.
• Chemoembolization followed by orthotopic liver transplant for epithelioid hemangioendotheliomaSt Peter SD, Moss AA, Huettl EA, Leslie KO, Mulligan DC. Chemoembolization followed by orthotopic liver transplant for epithelioid hemangioendothelioma. Clinical Transplantation 2003, 17: 549-553. PMID: 14756273, DOI: 10.1046/j.1399-0012.2003.00055.x.
• The spectrum of nonalcoholic fatty liver disease with normal liver enzymesBrandhagen D, Douglas D, Poterucha J, Burgart L, Rosen C, Mulligan D, Lindor K, Wiesner R, Angulo P. The spectrum of nonalcoholic fatty liver disease with normal liver enzymes. Gastroenterology 2003, 124: a717-a718. DOI: 10.1016/s0016-5085(03)83623-5.
• Early results of targeted prophylaxis for coccidioidomycosis in patients undergoing orthotopic liver transplantation within an endemic areaBlair JE, Douglas DD, Mulligan DC. Early results of targeted prophylaxis for coccidioidomycosis in patients undergoing orthotopic liver transplantation within an endemic area. Transplant Infectious Disease 2003, 5: 3-8. PMID: 12791068, DOI: 10.1034/j.1399-3062.2003.00005.x.
• Tacrolimus as a liver flush solution to ameliorate the effects of ischemia/reperfusion injury following liver transplantationSt. Peter SD, Post DJ, Rodriguez‐Davalos M, Douglas DD, Moss AA, Mulligan DC. Tacrolimus as a liver flush solution to ameliorate the effects of ischemia/reperfusion injury following liver transplantation. Liver Transplantation 2003, 9: 144-149. PMID: 12548508, DOI: 10.1053/jlts.2003.50018.
• Recent Advances in Liver TransplantationWiesner RH, Rakela J, Ishitani MB, Mulligan DC, Spivey JR, Steers JL, Krom RA. Recent Advances in Liver Transplantation. Mayo Clinic Proceedings 2003, 78: 197-210. PMID: 12583530, DOI: 10.4065/78.2.197.
• Effects of tacrolimus on ischemia‐reperfusion injurySt. Peter SD, Moss AA, Mulligan DC. Effects of tacrolimus on ischemia‐reperfusion injury. Liver Transplantation 2003, 9: 105-116. PMID: 12548502, DOI: 10.1053/jlts.2003.50020.
• 769 Rejection treatment modifies HCV quasispecies evolution after liver transplantationArenas J, Laskus T, Wilkinson J, Gallegos J, Fasola C, Adair D, Radowski M, Kibler K, Douglas D, Williams J, Netto G, Mulligan D, Klintmalm G, Rakela J, Vargas H. 769 Rejection treatment modifies HCV quasispecies evolution after liver transplantation. Hepatology 2003, 38: 532. DOI: 10.1016/s0270-9139(03)80811-x.
• Subcutaneous metastasis at a surgical drain site after the resection of pancreatic cancerSt. Peter SD, Nguyen CC, Mulligan DC, Moss AA. Subcutaneous metastasis at a surgical drain site after the resection of pancreatic cancer. Journal Of Gastrointestinal Cancer 2003, 33: 111. PMID: 14716058, DOI: 10.1385/ijgc:33:2-3:111.
• Amelioration of hepatic ischemia/reperfusion injury using indolepropionic acidLefler SR, St. Peter SD, Rodriguez-Davalos MI, Perumean JC, Spence NA, Moss AA, Mulligan DC. Amelioration of hepatic ischemia/reperfusion injury using indolepropionic acid. Transplantation Proceedings 2002, 34: 3065-3066. PMID: 12493376, DOI: 10.1016/s0041-1345(02)03616-3.
• Activation Time Course of Activator Protein-1 and Effect of Proline Dithiocarbamate During Ischemia-Reperfusion in Rat Skeletal MuscleLefler SR, Lille ST, Huemer G, Tucker R, Murray T, Schoeller T, Mulligan DC. Activation Time Course of Activator Protein-1 and Effect of Proline Dithiocarbamate During Ischemia-Reperfusion in Rat Skeletal Muscle. Annals Of Plastic Surgery 2002, 49: 654-659. PMID: 12461450, DOI: 10.1097/00000637-200212000-00016.
• Detection of hepatitis C virus sequences in brain tissue obtained in recurrent hepatitis C after liver transplantationVargas HE, Laskus T, Radkowski M, Wilkinson J, Balan V, Douglas DD, Harrison ME, Mulligan DC, Olden K, Adair D, Rakela J. Detection of hepatitis C virus sequences in brain tissue obtained in recurrent hepatitis C after liver transplantation. Liver Transplantation 2002, 8: 1014-1019. PMID: 12424714, DOI: 10.1053/jlts.2002.36393.
• A randomized, prospective, double-blinded evaluation of selective bowel decontamination in liver transplantationHellinger WC, Yao JD, Alvarez S, Blair JE, Cawley JJ, Paya CV, O’Brien P, Spivey JR, Dickson RC, Harnois DM, Douglas DD, Hughes CB, Nguyen JH, Mulligan DC, Steers JL. A randomized, prospective, double-blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation 2002, 73: 1904-1909. PMID: 12131685, DOI: 10.1097/00007890-200206270-00009.
• Thrombendvenectomy for Organized Portal Vein Thrombosis at the Time of Liver TransplantationMolmenti EP, Roodhouse TW, Molmenti H, Jaiswal K, Jung G, Marubashi S, Sanchez EQ, Gogel B, Levy MF, Goldstein RM, Fasola CG, Elliott EE, Bursac N, Mulligan D, Gonwa TA, Klintmalm GB. Thrombendvenectomy for Organized Portal Vein Thrombosis at the Time of Liver Transplantation. Annals Of Surgery 2002, 235: 292-296. PMID: 11807371, PMCID: PMC1422428, DOI: 10.1097/00000658-200202000-00019.
• Renal cell carcinoma metastatic to pancreasAbbas M, Collins J, Mulligan D. Renal cell carcinoma metastatic to pancreas. The American Journal Of Surgery 2001, 182: 183-184. PMID: 11574093, DOI: 10.1016/s0002-9610(01)00677-8.
• Mayo end-stage liver disease (MELD) score: Causes of variablitity in patients with end-stage liver disease (ESLD)Yousfi M, Douglas D, Malinchoc M, Mulligan D, Rakela J, Moss A, Harrison M, Balan V. Mayo end-stage liver disease (MELD) score: Causes of variablitity in patients with end-stage liver disease (ESLD). Gastroenterology 2001, 120: a371. DOI: 10.1016/s0016-5085(08)81846-x.
• Increased prevelance of osteoporosis in patients with end-stage liver diseasse secondary to hepatitis C infection and alcoholYOSFI M, DOUGLAS D, RAKELA J, SAVAGEIII W, MULLIGAN D, HARRISON M, VARGAS H, EBERHARD K, MOSS A, BALAN V. Increased prevelance of osteoporosis in patients with end-stage liver diseasse secondary to hepatitis C infection and alcohol. Gastroenterology 2001, 120: a378-a378. DOI: 10.1016/s0016-5085(01)81877-1.
• Mayo end-stage liver disease (MELD) score: Causes of variablitity in patients with end-stage liver disease (ESLD)YOUSFI M, DOUGLAS D, MALINCHOC M, MULLIGAN D, RAKELA J, MOSS A, HARRISON M, BALAN V. Mayo end-stage liver disease (MELD) score: Causes of variablitity in patients with end-stage liver disease (ESLD). Gastroenterology 2001, 120: a371-a371. DOI: 10.1016/s0016-5085(01)81846-1.
• Increased prevelance of osteoporosis in patients with end-stage liver diseasse secondary to hepatitis C infection and alcoholYosfi M, Douglas D, Rakela J, Savage W, Mulligan D, Harrison M, Vargas H, Eberhard K, Moss A, Balan V. Increased prevelance of osteoporosis in patients with end-stage liver diseasse secondary to hepatitis C infection and alcohol. Gastroenterology 2001, 120: a378. DOI: 10.1016/s0016-5085(08)81877-x.
• Inhibition of the initial wave of NF‐κB activity in rat muscle reduces ischemia/reperfusion injuryLille S, Lefler S, Mowlavi A, Suchy H, Boyle E, Farr A, Su C, Frank N, Mulligan D. Inhibition of the initial wave of NF‐κB activity in rat muscle reduces ischemia/reperfusion injury. Muscle & Nerve 2001, 24: 534-541. PMID: 11268026, DOI: 10.1002/mus.1037.
• The effect of orthotopic liver transplantation on the QTc interval in patients with end-stage liver diseaseCarey E, Mulligan D, Balan V, Harrison M, Rakela J, Douglas D. The effect of orthotopic liver transplantation on the QTc interval in patients with end-stage liver disease. The American Journal Of Gastroenterology 2000, 95: 2507. DOI: 10.1111/j.1572-0241.2000.02690.x.
• CASE REPORT: Colonic Perforation in Unsuspected Amebic ColitisAbbas M, Mulligan D, Ramzan N, Blair J, Smilack J, Shapiro M, Lidner T, Olden K. CASE REPORT: Colonic Perforation in Unsuspected Amebic Colitis. Digestive Diseases And Sciences 2000, 45: 1836-1841. PMID: 11052328, DOI: 10.1023/a:1005561607130.
• 19 Portal vein thrombendvenectomy in cases of portal vein thrombosis at the time of liver transplantationMolmenti E, Roodhouse T, Jaiswal K, Jennings L, Sanchez E, Marubashi S, Jung G, Brooks B, Conkey A, Mulligan D, Levy M, Goldstein R, Fasola C, Gonwa T, Klintmalm G. 19 Portal vein thrombendvenectomy in cases of portal vein thrombosis at the time of liver transplantation. Liver Transplantation 2000, 6: c5. DOI: 10.1016/s1527-6465(05)80048-6.
• Elevated alpha-fetoprotein levels in chronic hepatitis C patients without hepatocellular carcinomaKalathil S, Douglas D, Harrison E, Anderson M, Hentz J, Mulligan D, Jorge R. Elevated alpha-fetoprotein levels in chronic hepatitis C patients without hepatocellular carcinoma. Gastroenterology 2000, 118: a1453. DOI: 10.1016/s0016-5085(00)81711-4.
• Hepatitis C related cardiomyopathy: Fact or fiction?alathil S, ouglas D, nderson M, ppleton C, Harrison E, Hentz J, Mulligan D, Nelson L, Rakela J. Hepatitis C related cardiomyopathy: Fact or fiction? Gastroenterology 2000, 118: a1453. DOI: 10.1016/s0016-5085(00)81712-6.
• PORTAL VEIN THROMBENDVENECTOMY IN CASES OF ORGANIZED PORTAL VEIN THROMBOSIS AT THE TIME OF LIVER TRANSPLANTATION.Molmenti E, Roodhouse T, Jaiswal K, Jennings L, Sanchez E, Marubashi S, Jung G, Brooks B, Conkey A, Mulligan D, Levy M, Goldstein R, Klintmalm G. PORTAL VEIN THROMBENDVENECTOMY IN CASES OF ORGANIZED PORTAL VEIN THROMBOSIS AT THE TIME OF LIVER TRANSPLANTATION. Transplantation 2000, 69: s176. DOI: 10.1097/00007890-200004271-00242.
• REMOTE CONTROL: OUTCOMES UTILIZING TELEMEDICINE FOR OFF-SITE PRE-TRANSPLANT EVALUATION AND POST-TRANSPLANT LONG-TERM CARE.Kalathil S, Douglas D, Mulligan D, Harrison M, Anderson M, Nelson L, Wiesner R, Rakela J. REMOTE CONTROL: OUTCOMES UTILIZING TELEMEDICINE FOR OFF-SITE PRE-TRANSPLANT EVALUATION AND POST-TRANSPLANT LONG-TERM CARE. Transplantation 2000, 69: s369. DOI: 10.1097/00007890-200004271-00989.
• CURRENT APPROACH TO THE UTILIZATION OF LIVER DONORS POSITIVE FOR EITHER ANTI-HBC OR ANTI-HCV IN THE UNITED STATES.Douglas D, Pasha T, Mulligan D, Nelson L, Byrne T, Hemker J, Wiesner R. CURRENT APPROACH TO THE UTILIZATION OF LIVER DONORS POSITIVE FOR EITHER ANTI-HBC OR ANTI-HCV IN THE UNITED STATES. Transplantation 1999, 67: s656. DOI: 10.1097/00007890-199905150-00476.
• ASSOCIATION OF HEPATITIS C WITH SUBCLINICAL REACTIVATION OF HEPATITIS B VIRAL DNA DETECTED BY POLYMERASE CHAIN REACTION (PCR) IN ALLOGRAFTS OF RECIPIENTS WITH APPARENT IMMUNITY TO HEPATITIS BDouglas D, Abdelmaleck M, Pasha T, Mulligan D, Persing D, Wiesner R. ASSOCIATION OF HEPATITIS C WITH SUBCLINICAL REACTIVATION OF HEPATITIS B VIRAL DNA DETECTED BY POLYMERASE CHAIN REACTION (PCR) IN ALLOGRAFTS OF RECIPIENTS WITH APPARENT IMMUNITY TO HEPATITIS B. Transplantation 1999, 67: s631. DOI: 10.1097/00007890-199905150-00379.
• A Prospective Longitudinal Analysis of ATGAM Induction Versus Mycophenolate Mofetil Maintenance Immunosuppression for Orthotopic Liver TransplantationMulligan D, Bush W, Shiffrin F, Cowan R, Penko M, Sterling R, Post A, Schulak J. A Prospective Longitudinal Analysis of ATGAM Induction Versus Mycophenolate Mofetil Maintenance Immunosuppression for Orthotopic Liver Transplantation. Transplantation 1998, 66: s51. DOI: 10.1097/00007890-199810270-00233.
• Cost analysis of four strategies for prevention of CMV infection in liver transplant recipientsPost AB, Mulligan DC, Bush W. Cost analysis of four strategies for prevention of CMV infection in liver transplant recipients. Transplantation Proceedings 1998, 30: 2102-2103. PMID: 9723406, DOI: 10.1016/s0041-1345(98)00553-3.
• USE OF ETA AND ETA +B RECEPTOR ANTAGONISTS IN ATTENUATING HEPATIC ISCHEMIA/REPERFUSION INJURYMulligan D, Stowe N, Wilhelm S, Post A, Post A, Robinson A, Schulak J. USE OF ETA AND ETA +B RECEPTOR ANTAGONISTS IN ATTENUATING HEPATIC ISCHEMIA/REPERFUSION INJURY. Transplantation 1998, 65: s43. DOI: 10.1097/00007890-199806270-00181.
• USE OF ETA AND ETA +B RECEPTOR ANTAGONISTS IN ATTENUATING HEPATIC ISCHEMIA/ REPERFUSION INJURY.Mulligan D, Stowe N, Wilhelm S, Post A, Robinson A, Schulak J. USE OF ETA AND ETA +B RECEPTOR ANTAGONISTS IN ATTENUATING HEPATIC ISCHEMIA/ REPERFUSION INJURY. Transplantation 1998, 65: 119. DOI: 10.1097/00007890-199805131-00162.
• RESOLUTION OF SPUR CELL ANEMIA WITH LIVER TRANSPLANTATIONChitale AA, Sterling RK, Post AB, Silver BJ, Mulligan DC, Schulak JA. RESOLUTION OF SPUR CELL ANEMIA WITH LIVER TRANSPLANTATION. Transplantation 1998, 65: 993-995. PMID: 9565106, DOI: 10.1097/00007890-199804150-00021.
• Abdominal Catastrophe: Visceral Injury as a Cause of Peritonitis in Patients Treated by Peritoneal DialysisHarwell C, Newman L, Cacho C, Mulligan D, Schulak J, Friedlander M. Abdominal Catastrophe: Visceral Injury as a Cause of Peritonitis in Patients Treated by Peritoneal Dialysis. Advances In Peritoneal Dialysis 1997, 17: 586-594. PMID: 9655159, DOI: 10.1177/089686089701700611.
• Influence of steroid withdrawal on proteinuria in renal allograft recipients.Ghandour FZ, Knauss TC, Mulligan DC, Schulak JA, Hricik DE. Influence of steroid withdrawal on proteinuria in renal allograft recipients. Clinical Transplantation 1997, 11: 395-8. PMID: 9361929.
• Reduction of early rejection in adult liver transplantation with ATG induction therapySchulak J, May E, Post A, Fasola C, Mulligan D, Sterling R. Reduction of early rejection in adult liver transplantation with ATG induction therapy. Transplantation Proceedings 1997, 29: 555-556. PMID: 9123126, DOI: 10.1016/s0041-1345(96)00264-3.
• Intrathymic spleen cell inoculation and ALS fails to induce tolerance to rat pancreas allograftsSchulak JA, Mulligan DC, Robinson A. Intrathymic spleen cell inoculation and ALS fails to induce tolerance to rat pancreas allografts. Transplantation Proceedings 1997, 29: 1070-1071. PMID: 9123203, DOI: 10.1016/s0041-1345(96)00405-8.
• Monitoring of allograft recipients for the development of HLA-specific antibodies: elimination of OKT3 as a complicating factor.Mulligan D, Gentry L, Dombrausky L, Klintmalm G, Nikaein A. Monitoring of allograft recipients for the development of HLA-specific antibodies: elimination of OKT3 as a complicating factor. Clinical Transplantation 1995, 9: 438-41. PMID: 8645885.
• Should liver transplantation be performed for hepatitis B?Mulligan DC, Klintmalm GB. Should liver transplantation be performed for hepatitis B? Clinical Transplantation 1995, 9: 246-8. PMID: 7670170.
• Use of anti-hepatitis C virus seropositive organs in liver transplantation.Mulligan DC, Goldstein RM, Crippin JS, Abouljoud MS, Levy MF, Husberg BS, Gonwa TA, Foster BR, Tillery GW, Klintmalm GB. Use of anti-hepatitis C virus seropositive organs in liver transplantation. Transplantation Proceedings 1995, 27: 1204-5. PMID: 7878850.
• QUALITY OF LIFE IMPROVEMENTS AT ONE, TWO, AND FIVE YEARS AFTER LIVER TRANSPLANTATION1,2Levy M, Jennings L, Abouljoud M, Mulligan D, Goldstein R, Husberg B, Gonwa T, Klintmalm G. QUALITY OF LIFE IMPROVEMENTS AT ONE, TWO, AND FIVE YEARS AFTER LIVER TRANSPLANTATION1,2. Transplantation 1995, 59: 515-518. PMID: 7878756, DOI: 10.1097/00007890-199502270-00013.
• QUALITY OF LIFE IMPROVEMENTS AT ONE, TWO, AND FIVE YEARS AFTER LIVER TRANSPLANTATION1,2Levy M, Jennings L, Abouljoud M, Mulligan D, Goldstein R, Husberg B, Gonwa T, Klintmalm G. QUALITY OF LIFE IMPROVEMENTS AT ONE, TWO, AND FIVE YEARS AFTER LIVER TRANSPLANTATION1,2. Transplantation 1995, 59: 515-518. DOI: 10.1097/00007890-199559040-00013.
• A Comparison Of Treatment With Transjugular Intrahepatic Portosystemic Shunt Or Distal Splenorenal Shunt In The Management Of Variceal Bleeding Prior To Liver TransplantationAbouljoud M, Levy M, Rees C, Diamond N, Lee S, Mulligan D, Goldstein R, Husberg B, Gonwa T, Klintmalm G. A Comparison Of Treatment With Transjugular Intrahepatic Portosystemic Shunt Or Distal Splenorenal Shunt In The Management Of Variceal Bleeding Prior To Liver Transplantation. Transplantation 1995, 59: 226-229. PMID: 7839445, DOI: 10.1097/00007890-199501270-00013.
• A Comparison Of Treatment With Transjugular Intrahepatic Portosystemic Shunt Or Distal Splenorenal Shunt In The Management Of Variceal Bleeding Prior To Liver TransplantationAbouljoud M, Levy M, Rees C, Diamond N, Lee S, Mulligan D, Goldstein R, Husberg B, Gonwa T, Klintmalm G. A Comparison Of Treatment With Transjugular Intrahepatic Portosystemic Shunt Or Distal Splenorenal Shunt In The Management Of Variceal Bleeding Prior To Liver Transplantation. Transplantation 1995, 59: 226-229. DOI: 10.1097/00007890-199501000-00013.
• Amiodarone-induced thyrotoxicosis: clinical presentation and expanded indications for thyroidectomy.Mulligan DC, McHenry CR, Kinney W, Esselstyn CB. Amiodarone-induced thyrotoxicosis: clinical presentation and expanded indications for thyroidectomy. Surgery 1993, 114: 1114-9. PMID: 8256216.
• Baylor update: outcome analysis in liver transplantation.Levy M, Goldstein R, Husberg B, Gonwa T, Backman L, Abouljoud M, Mulligan D, Klintmalm G. Baylor update: outcome analysis in liver transplantation. Clinical Transplants 1993, 161-73. PMID: 7918148.